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INTRODUCTION 
G E N E R A L 
HUMAN RED BLOOD CELL 
The mammalian red blood cell affords a simple 
experimentally accessible and useful membrane system for the 
study of many biological processes. It originates from the 
bone marrow as nucleated precursor that looses all the 
organelles and several cytoplasmic proteins during 
maturation through an intricate process of differentiation. 
In the absence of these, the mammalian erythrocyte relies 
mainly on plasma membrane for its shape (Lux, 1979). 
The human erythrocyte membrane is the best studied 
membrane system in view of its ready availability and ease 
of isolation. It is unusually durable, surviving thousands 
of passages through circulation during its 120 day life 
span. The basis for the resilience of the cell is the 
mechanical properties of the plasma membrane, since the 
usual cytoplasmic structural proteins and organelles are 
lost during differentiation (Bennet, 1985). Human 
erythrocyte membrane is a composite of two structural units 
viz. membrane cytoskeleton and membrane bilayer both of 
which are responsible for maintaining the shape and 
structural integrity of the mature erythrocytes (Elgsaeter 
et al., 1986). While the membrane bilayer is composed of 
lipids and integral membrane proteins, the cytoskeleton is a 
reticulate type of structure formed from three major 
proteins (spectrin, actin and polypeptide 4.1) and several 
minor peripheral proteins, and is associated with 
cytoplasmic face of the membrane bilayer through protein-
protein as well as protein-phospholipid interactions 
(Bennet, 1985). The plasma membrane of the red blood cell 
behaves like a semisolid with elastic properties which are 
not restricted by intracellular cytoskeletal network of 
protein but are mostly attributed to the matrix of membrane 
proteins (Kirkpatrick, 1976). The network of peripheral 
proteins of the cytoskeleton controls cell shape and 
provides the mechanical strength necessary to prevent 
rupture of the cell by the high shear forces experienced in 
blood capillaries (Clague and Cherry, 1989). The membrane 
bilayer skeleton association controls the lateral mobility 
of the integral membrane proteins (Sheetz, 1983) and is 
also considered a major factor in maintaining the asymmetric 
phospholipid distribution across the erythrocyte membrane 
bilayer (Haest, 1982). 
Red Blood Cell Membrane Protein Composition 
The human erythrocyte ghosts prepared according to 
Dodge et al. (1963) contain about 50% protein, 43% lipid and 
7% carbohydrate. The erythrocyte membrane contains atleast 
20 different polypeptide chains held together and to 
membrane lipids by ionic, dipole and hydrophobic forces. 
Fairbanks et al. (1971) identified and numbered the major 
membrane polypeptides on the basis of their mobility on SDS-
PAGE. Extensive literature is available on the nature and 
function of the principal polypeptides of human erythrocyte 
membrane (Juliano, 1973; Haest, 1982; Bennett, 1985). Only 
a brief account of the available information on these 
polypeptide is therefore presented. 
Spectrin (Bands 1 and 2): The spectrin network in 
combination with other proteins comprises the erythrocyte 
skeleton which seems to maintain the mechanical stability of 
the membrane and to control cell shape and deformability 
(Marchesi, 1979; Mohandas et al., 1983). The spectrin 
molecule is very flexible and contains two antiparallel, 
non-identical subunits that are intertwisted and appear as 
100 nm long and 2.5 nm wide rods in electron microscopy 
(Shotton et al., 1979). The rotational diffusion studies by 
Learmonth et al. (1989) showed that spectrin behaves neither 
as rigid rod nor as ,a compact globular protein. In addition 
to axial rotation of ribbon like spectrin molecule, faster 
motions such as intermolecular bending and torsional 
distortions are also observed suggesting internal 
flexibility of the spectrin dimer. The thiol groups of 
spectrin were considered to be involved in maintaining 
membrane resistance to thermal damage and in controlling 
self association of dimers (Streichman et al., 1988). 
Ankyrin (Bands 2.1, 2.2 and 2.3) : Ankyrin is a monomeric 
phosphoprotein (Bennet, 1979) and links the cytoskeletal 
network to the membrane by forming a bridge between beta 
chain of spectrin and the cytoplasmic domain of band 3 
(Tyler et al., 1980). The affinity of ankyrin for band 3 is 
controlled by a conformational equilibrium in cytoplasmic 
domain involving a bending motion around a central hinge 
(Thevenin and Low, 1988). Studies by Willardson et al. 
(1989) indicate that multiple sites of association of 
ankyrin contribute to its high affinity for band 3 
cytoplasmic domain. 
Band 3: It is an intrinsic and most abundant protein (Mr 
95,000) of the red blood cell membrane (Fairbanks et al. 
1971). The complete amino acid sequence of human anion 
transport protein has been deduced from cDNA sequence 
(Tanner et al., 1988). In native membrane only 15% of total 
band 3 monomer is associated with ankyrin (Bennet and 
Stenbuck, 1979). Ueno et al. (1987) suggested that a 
dynamic exchange of free band 3 for ankyrin linked band 3 
may occur in intact erythrocytes and this may contribute to 
the shape change of erythrocyte. 
Band 4.1 - The band 4.1 of Mr 78,000 is a globular molecule 
of 6 nm diameter (Tyler et al., 1979). It participates in 
the interaction of spectrin with actin (Cohen, 1983; Bennet, 
1985; Wolfe et al., 1980) and also interacts directly with 
actin and severs F-actin in vivo (Pinder et al., 1984). It 
anchors the skeleton to membrane via its association with 
glycophorin (Anderson and Lovrien, 1984), band 3 (Pasternack 
et al., 1985) and lipids (Cohen et al., 1988). The 
association of band 4.1 with erythrocyte membrane can be 
modulated in vitro by changes in the level of band 4.1 
phosphorylation (Danilov et al., 1990). 
Band 4.2: It has a Mr of 72,000 and exists in oligomeric 
form in membrane (Steck, 1972). Band 4.2 is found in 
association with cytoplasmic domain of band 3 (Korsgren and 
Cohen, 1986). It can form multiple association with membrane 
and membrane skeletal proteins (purified cytoplasmic domain 
of band 3, purified ankyrin and band 4.1) and may serve an 
yet unrecognised role in membrane organization (Korsgren and 
Cohen, 1988). 
Band 4.9: A further putative component of membrane skeleton 
is band 4.9 (Mr 48,000). Liu and Palek (1979) have reported 
its in situ association with band 2 of spectrin. It is a 
trimeric actin bundling protein (Siegel and Branton, 1985). 
Actin (Band 5): Band 5 polypeptide (Mr 43,000) is also a 
component of membrane skeleton and forms short oligomers 
containing about 10 molecules in filamentous form (Brenner 
and Korn, 1980). Each spectrin tetramer has two actin 
binding sites at the free end. This polypeptide has been 
shown to play a major role in shape change of erythrocytes. 
Band 6: This is the monomer of glyceraldehyde-3-phosphate 
dehydrogenase. This enzyme is a tetramer of Mr 35,000 
subunits which binds to spectrin-actin complex and to band 
3(Yeltman and Harris, 1980; Murthy et al., 1981). The 
binding of band 6 to the cytoplasmic domain of human 
erythrocyte glucose transport protein was studied by 
Lachaal et al. (1990). This study suggests that a 
significant portion of the enzyme may exist in association 
with the glucose transporter in vivo. 
Band 7: This protein of Mr 29,000 has not yet been fully 
characterized and it is also not clear as to where and how 
it is arranged in erythrocyte membrane. The 
phosphatidylserine transporter protein of human erythrocyte 
membrane has been shown to co-migrate with band 7 protein 
(Connor and Schroit, 1988). 
In addition to these polypeptides, there are a number 
of glycoproteins embedded in the lipid bilayer of 
erythrocyte membrane. They comprise approximately 10% of the 
total membrane protein. Glycophorin A is the major 
glycoprotein of erythrocyte membrane. 
Red Blood Cell Lipid Composition and Organization 
Studies on red blood cell lipid bilayer has been 
guite extensively reviewed (Stephen et al., 1972; Op den 
Kamp, 1979). The lipid bilayer is in liquid crystalline 
state and highly anisotropic. The lipid composition of 
erythrocyte is rather complex due to the occurrence of 
several variants both in the polar and non-polar moieties of 
the molecule and appears to be highly conserved (Kuypers et 
al., 1984a). This conservation serves to maintain the 
specific membrane properties such as permeability and 
resistance against mechanical and osmotic stress. The amount 
of total lipid in 10•'•'^  cells is about 5mg and approximately 
10^ lipid molecules have been reported in the plasma 
membrane of a single red blood cell, 30% of which comprises 
neutral lipids, 60% phospholipids and 5-10% glycolipids 
(Cooper, 1969). Cholesterol, the major constituent of the 
neutral lipids, appear to be relatively randomly distributed 
in the bilayer (Higgins et al., 1973). Freeze fracture 
studies, however, indicate that outer layer may contain more 
cholesterol than the inner layer of the bilayer (Fischer, 
1975). 
The various phospholipids present in the erythrocyte 
membrane belong to either of the three classes namely 
phosphatides, phosphoinositides and plasmalogens also called 
ether lipids. The commonly occurring phospholipids in the 
human plasma membrane are phosphatidylcholine, phosphatidyl-
serine, phosphatidylethanolamine and sphingomyelin (Cooper, 
1969) and they constitute 32.06%, 13.54%, 30.28% and 22.15% 
respectively of the total phospholipids. Other minor 
phospholipids are phosphatidic acid and phosphatidyl-
inositol which constitute about 1.91% and 1.06% of the total 
phospholipids respectively (Jain and Shohet, 1981). Of the 
various phospholipid classes, ether phospholipids are found 
only in phosphatidylethanolamine and constitute about 47% 
of total (Rogiers, 1980). About 7% has also been reported in 
phosphatidylcholine (Myher et al., 1989). 
Modifications in red blood cell lipid composition has 
however been reported with aging by Prisco et al. (1991). 
There was a significant increase in cholesterol and total 
phospholipid content with aging where as no difference was 
observed in cholesterol/phospholipid molar ratio. Noticable 
increase in palmitic and stearic acids esterified in 
phosphatidylcholine and phosphatidylethanolamine 
respectively were also seen. Sumikawa et al. (1993) showed 
that physical training and acute exercise also effects the 
red blood cell membrane phospholipid composition. Both 
processes decrease phosphatidylserine and polyunsaturated 
fatty acids, possibly due to lipid peroxidation. The 
phospholipid composition remains rather similar during the 
whole 120 days life span of human erythrocyte (Van Deenen 
and De Gier, 1974; and Phillips et al., 1969). The 
phospholipid composition of erythrocytes is not 
significantly affected by diet (De-Gier, 1968; Vajreswari et 
al., 1983; Shand and Nobel, 1981; Ehrstrom et al., 1981). 
Unlike other cell types, the red blood cells do not possess 
enzymes for de novo formation of phospholipid. They must be 
derived from the original membrane synthesized in the bone 
marrow (Nelson, 1972) or from limited exchange of intact 
phospholipid with plasma lipoproteins, which is believed to 
be catalyzed by specific phospholipid exchange proteins (Van 
Meer et al., 1980), as well as limited exchange of acyl 
groups within the erythrocyte membrane (Shohet, 1971). The 
red blood cell sphingomyelin originates in the bone marrow 
and do not undergo further metablolism in the membrane 
(Nelson, 1972). The extensive differences noted among the 
different phospholipid classes emphasize the metabolic 
heterogeneity of the red blood cell phospholipids, which 
must reflect some as yet unrecognized physiological 
requirement. 
The fatty acid composition of the human erythrocyte 
membrane phospholipids has been investigated in detail and 
those ranging from 0^4 to C24 with varying number of double 
bonds have been reported (Manku et al., 1983; Alexander and 
Justice, 1985; Peuchant et al., 1989). Branched chain iso 
and anti-iso isomers of fourteen, eighteen and twenty carbon 
atoms fatty acid and fatty aldehydes, have also been 
reported in human erythrocyte membrane (Alexander and 
Justice, 1985). All the fatty acids detected belonged to one 
of the three families of fatty acids namely (n-3), (n-6) and 
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(n-9). The levels of n-3 polyunsaturated fatty acid have 
been reported to be effected by diet. Hessel et al. (1990) 
showed an increase in the content of polyunsaturated n-3 
fatty acids in subjects fed fresh water fish. Hagve et al. 
(1993) also reported a significant increase in n-3 fatty 
acids in fish oil supplemented subjects mainly at the 
expense of linoleic acid (18:2, n-6) and oleic acid (18:1). 
No significant change was however observed in the relative 
amount of arachidonic acid (20:4, n-6). 
Changes in fatty acid composition of erythrocyte 
membrane have been observed under diseased conditions 
also. Girelli et al. (1992) showed a decrease in 
polyunsaturated fatty acid in patients of continuous 
ambulatory peritoneal dialysis. Similar observations have 
been made in erythrocyte membrane of insulin dependent 
diabetic patients (Ruiz-Gutierrez et al., 1993) and in 
alcoholics (Gatti et al., 1993). 
Based on the fatty acid composition of the 
phospholipid molecules, nearly 200 molecular species 
belonging to either of the three subclasses of phospholipids 
namely diacyl, alkenylacyl and alkylacyl phospholipids were 
identified by Myher et al. (1989) in human erythrocyte 
membrane. The phosphatidylcholine contains 93% diacyl, 4.6% 
alkylacyl and 2.5% alkenylacyl, while phosphatidyl-
ethanolamine are made up of 48.8% diacyl, 47.7% alkenyacyl 
and 3.4% alkylacyl phospholipids. No significant alkylacyl 
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and alkenylacyl species were however found in human 
erythrocyte phosphatidylserine and phosphatidylinositol 
(Myher et al., 1989). The major molecular species of the 
diacyl phosphatidylcholine compared favourably with 
selected earlier analysis carried out by Van Golde et al. 
(1967), Marai and Kuksis (1969) and Child et al. (1985). 
There appears to have been no previous analyses of the 
molecular species of the alkylacyl and alkenyl acyl 
phosphatidylcholine and phosphatidylethanolamine, although 
the presence of both alkylacyl and alkenylacyl subclasses in 
red blood cell phosphatidylethanolamine had been recognized 
(Diagne et al., 1984; Antoku et al., 1985). 
Myher et al. (1989) showed that long chain 
polyunsaturated fatty acids, were mainly combined with 0^ 5 
in all phosphatidylcholine subclasses and diacyl 
phosphatidylethanolamine, and with C^g i^i the diacyl 
phosphatidylinositol, phosphatidylserine and alkylacyl as 
well as alkenylacyl phosphatidylethanolamine. They further 
reported that ether phospholipids, contained significant 
proportion of C2Q, Q.22 ^ ""^  ^ 24 fatty acids in addition to 
C25 and C-j^g alkyl and alkenyl fatty acid chain. 
The nature of the fatty acid present in the 
phospholipid molecule has a profound effect on the 
properties of cell. Op den Kamp et al. (1985) showed that 
the fragility of erythrocyte and their susceptibility 
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towards osmotic shock is governed by the fatty acid 
composition. Retailoring the native phosphatidylcholine with 
more saturated or with more unsaturated species results in 
substantial modifications of membrane structure and function 
and ultimately leads to erythrocyte hemolysis (Op den Kamp 
et al., 1985 and Kuypers et al., 1984a). 
Lange et al. (1980) and Kuypers et al. (1984b) 
showed that erythrocyte shape also depends upon the type of 
fatty acids present in the phospholipid molecules. They 
showed that increase in disaturated phosphatidylcholine 
species caused the cells to become echinocyte while 
dilinoleoyl phosphatidylcholine favoured stomatocytic shape. 
The changes in shapes result from the differences in the 
geometry of individual phosphatidylcholine molecules 
suggesting that replacement of one species by another may 
disturb the pre-existing packing of lipid molecules in the 
membrane. 
Red Blood Cell Antioxidant System 
The erythrocyte under physiological condition is 
continuously exposed to oxidants such as the superoxide 
radical (03"') (Suzuki et al., 1984). These radicals are 
also produced under experimental and/or clinical use of some 
oxidizing drugs such as phenylhydrazine and premaguine, 
inhaled gases, aromatic xenobiotics, radiation and activated 
neutrophils. Mammalian red blood cell is particularly 
susceptible to oxidative damage because (i) being an oxygen 
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carrier, it is exposed uninterruptedly to high oxygen 
tension (ii) it has no capacity to repair its damaged 
components and (iii) the hemoglobin is susceptible to 
autoxidation and its membrane components to lipid 
peroxidation. However, the erythrocytes have a protective 
mechanism against oxidative damage by some ways of certain 
enzyme systems. 
Three main enzymes, glutathione peroxidase (GSH-Px), 
catalase (CAT) and superoxide dismutase (SOD) are known to 
protect the erythrocyte against such damage. Another enzyme, 
glutathione reductase (GR) is of importance in maintaining 
an adequate level of reduced glutathione (GSH). Two more 
enzymes of pentose phosphate pathway i.e. glucose-6-
phosphate dehydrogenase and 6-phosphogluconate dehydrogenase 
also assist in protection by providing the NADPH required by 
GR to convert oxidized glutathione (GSSG) to GSH (Suzuki et 
al., 1984). 
The membrane bound GSH-Px (Hill & Thornally , 1983) 
plays an important role in the elimination of H2O2 under 
physiological conditions (Kurata et al., 1993). It requires 
GSH as a cofactor for the breakdown of H2O2. There is a 
wide variation in GSH-Px activity in mammalian erythrocytes 
(Kurian and Iyer, 1977; Maral et al., 1977, Agar and Suzuki, 
1982, Suzuki et al., 1984). Suzuki et al. (1984) showed that 
in human erythrocytes the activity of GSH-Px is lower as 
compared to ruminants especially, goat and buffalo 
erythrocytes. Even sexual variation in enzyme activity in 
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human erythrocyte has been reported recently (Guemouri et 
al., 1991). 
Catalase which also catalyzes the dissemination of 
H2O2 has been reported to play a minor role as compared to 
GSH-Px under physiological conditions (Cohen and Hochstein, 
1963). Only at higher concentration of H2O2, the 
decomposition of H2O2 hy catalase hecomes prominent. The red 
blood cell catalase activity shows variation among the 
various mammalian species (Suzuki et al., 1984 & 1985; 
Paniker and Iyer, 1965). Ruminants like goat, buffalo, sheep 
and cattle erythrocyte have lower catalase activity as 
compared to human erythrocyte. 
The Cu, Zn-SOD of erythrocytes, that catalyzes the 
dismutation of 02~ to H2O2 is uniformly distributed among 
various mammals (Maral et al., 1977; Suzuki et al., 1985). 
However, it was found to be lacking in buffalo and golden 
hamster (Suzuki et al., 1984). 
As the active xenobiotic metabolism is lacking in 
erythrocytes (Awasthi et al., 1981), the glutalhione-S-
transferase serves to detoxify foriegn molecules from the 
blood stream by forming GSH xenobiotic conjugates that are 
transported from the cell by membrane transport system 
(Awasthi et al. , 1981; Board, 1981 & 1984; Kondo et al., 
1982) . 
Besides these enzyme systems, the glutathione also 
exerts protective effect against oxidative stress and 
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toxic agents by virtue of being a substrate for GSH-Px and 
glutathione-S-transferase (Kurata et al., 1993). Removal of 
oxygen radicals non-enzymatically by glutathione has also 
been reported (Wefers & Sies 1983). Protein thiols (Wayner 
et al., 1987) and a-tocopherol (Burton et al., 1983; Mino et 
al.,1989) have also been suggested to contribute to the 
antioxidant capacity in erythrocyte membrane. 
NON-HTUMANOID RED BLOOD CELL 
Compared to the detailed information available on 
human erythrocytes, that on non-humanoid erythrocyte is 
limited. There, however, seems to exist considerable 
similarity in the properties of erythrocytes from all 
vertebrates which attests the generality and importance of 
this cell. Many mammalian erythrocytes however, show clear 
variations in structure and physiology from the human 
erythrocytes. 
Considerable differences occur in the size and shape 
of erythrocytes derived from various mammals. Goat and sheep 
erythrocytes are smaller than the human erythrocyte and are 
triangular or irregular in shape (Jain et al., 1980). The 
goat erythrocyte has a mean diameter about 2/3 that of sheep 
and about 1/2 that of human and is quite variable in shape 
(Schalm et al., 1975). Bovine erythrocytes are discoidal in 
shape like the human, while the chicken erythrocytes are 
ellipsoidal and nucleated (Majumdar and Baker, 1980). Camel 
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erythrocytes appear as flattened ellipsoids (Ralston 1975). 
Although all mammalian erythrocytes are anucleated 
and exhibit remarkable similarities in behaviour, striking 
differences have been observed in various calcium related 
processes. Sheep erythrocyte membrane exhibits very low 
membrane (Ca^ "''-Mg^ ''")-ATPase activity (Vincenzi, 1981) and 
rigidity to Ca^ "*"-induced alterations (Eaton et al., 1978). 
Goat erythrocytes contain barely detectable (Ca -Mg )-
ATPase activity (Vincenzi, 1981). They also lack Ca^ "*"-
induced transglutaminase stimulated membrane crosslinking 
and membrane protein degradation (Khan and Saleemuddin, 
1988). The goat and sheep erythrocytes are also deficient in 
Ca sensitive phosphoinositide phosphodiesterase (Allan and 
Michell, 1977) and do not show membrane protein 
phosphorylation in response to Ca^ "*" and Ca -ionophore 
treatment (Raval and Allan, 1985). Cow and horse 
erythrocytes also show very low (Ca^ ''"-Mg^ '^ )-ATPase activity 
unlike human erythrocytes. 
On the contrary the polypeptide composition of 
mammalian erythrocyte membrane like those of sheep, human, 
rat, pig and dog showed remarkable similarity (Lenard, 1970) 
and it was seen that the prominent molecular weight classes 
of erythrocyte membrane proteins were found in all species 
examined. Among the prominent bands which appear to be 
species specific are the sheep band of Mr 160,000 and the 
pig band of Mr 53,000 (Lenard, 1970). A common group of 
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polypeptides (at least 9) with similar individual molecular 
weights have been demonstrated in erythrocyte membrane of 
pig, cow, cat, dog and human (Kobylka et al., 1972). The 
bovine band 3 appears to be similar in molecular disposition 
to that of human band 3 though it exhibits a slightly higher 
molecular weight (Makino et al., 1981). Band 3 protein in 
the goat erythrocyte has been found to have an unusual 
organisation (Khan et al., 1990). The variability in band 3 
protein among species appears to be confined largely to the 
extreme N-terminal region (Jay 1983, Kopito and Lodish, 
1985). 
A transmembrane protein analogous to glycophorin of 
human erythrocyte has been characterized in goat erythrocyte 
(Inaba and Maeda, 1988). This protein of Mr 155,000, (gp 
155) has been observed in other ruminants like sheep, cow 
and deer also. 
The glycoprotein composition of erythrocyte membrane 
derived from various animal species have also been compared 
(Lenard, 1970). Among the various species studied, the 
glycoprotein composition appears to differ more markedly 
than the membrane polypeptides. 
Significant differences have been noted in the 
phospholipid composition of erythrocytes from various 
mammalian species, especially those from the ruminants 
(Nelson, 1967). Total lipid composition per red blood cell 
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was found to be highly variable among the various mammalian 
species (Nelson, 1967). This reflected a wide range in mean 
corpuscular volume of erythrocytes from different species 
(Ponder, 1948). Unlike cholesterol or total phospholipid, 
glycolipid shows more species variations, with gangliosides 
ranging from 2% to 16% and other glycolipids from 1% to 18% 
in cow, goat, rabbit, pig, horse, sheep, rat and guinea pig 
(Nelson, 1967). 
Among the various phospholipds, cardiolipin was 
absent in the erythrocytes of all the mammalian species, 
while choline phospholipid was found to be absent in true 
ruminants, (Turner, 1957; Nelson, 1967). In contrast, the 
erythrocytes of the horse, a pseudoruminant are high in 
lecithin. Sphingomyelin accounted for about 50% of the total 
phospholipids in ruminants as compared to human erythrocytes 
(Op den Kamp, 1979) and horse (Nelson 1967), but is never 
zero as is the lecithin of the true ruminant. The 
aminophospholipid, phosphatidyl- ethanolamine varied between 
a low of 21.5% in the rat and a high of 31.9% in the rabbit, 
while phosphatidylserine varied over a slightly greater 
range from 11% in the rat to 21% in the goat. Phosphatidic 
acid and phosphatidylinositol constituted less than 5% of 
the total phospholipids in almost all mammalian species 
(Nelson,1967). White,(1973) reported 30% phosphatidylserine, 
6% phosphatidic acid and 5% phosphatidylinositol in goat,cow 
and sheep erythrocytes. 
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Diagne et al., (1984) reported ether phospholipids in 
the erythrocytes of other mammalian species like rat and 
guinea pig, besides human erythrocyte. Major ether 
phospholipids were the ethanolamine plasmalogens, with 
significant differences between the three mammalian species 
(13%, 31% and 53% of phosphatidylethanolamine in guinea pig, 
human and rat respectively). Alkyl ether phospholipids were 
equally distributed between phosphatidylcholine and 
phosphatidylethanolamine, alkylacyl phosphatidylcholine 
being found in highest amounts in guinea pig. 
Analysis of the phospholipid orientation in bovine 
and goat erythrocytes, using phospholiphase A2 as a probe, 
revealed that 18% of phosphatidylethanolamine and 12% of 
phosphatidylserine in the case of goat erythrocytes and 
10% of phosphatidylserine in bovine erythrocytes were 
localized in external leaflet of the bilayer unlike the 
human erythrocyte where there is absolute asymmetry for 
phosphatidylserine (Farooqui et al., 1987). 
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L I P I D P E R O X I D A T I O N 
Oxygen is essential for life of aerobes but it has 
also been known to be toxic at concentration only slightly 
greater than that present in normal air (Haugaard, 1968). 
The biochemical mechanism responsible for oxygen toxicity 
include lipid peroxidation and generation of H2O2 and 
superoxide free radical. Certain cells such as phagocytes 
have evolved to utilize 02"' and H2O2 for purposeful 
activity beneficial to cell (Baboir, 1978) but most cells 
require protection against excessive production of these 
intermediates (Fridovich, 1983). Superoxide radical (02~') 
and H2O2 are themselves poorly reactive in aqueous 
solution and unable to oxidatively modify molecules such as 
DNA, lipids and proteins (Gutteridge and Quinlan, 1992). 
However, excessive generation of these in biological system 
may invariably lead to molecular damage. 
The deleterious effects of oxidative damage on 
proteins and lipids are of paramount interest in biological 
and biomedical research (Halliwell and Gutteridge, 1986; 
Fridovich, 1986; Kontos, 1985; Gaudel and Duvelleroy, 
1984). Oxidative stress induces numerous types of 
alterations in biological membranes. Among the structural 
manifestations, are peroxidation of lipids (Kappus, 1985; 
Buege and Aust, 1978) and oxidation of proteins (Buege and 
Aust, 1978; Wolff et al. , 1986; Zs Nagy and Floyd, 1984). 
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Lipid peroxidation results in a variety of biochemical and 
biophysical changes in the membrane (Plaa and Witschi, 1976; 
Vladimirov et al., 1980). The various biochemical changes 
concomitant upon peroxidation are inhibition of, membrane 
bound enzyme (Stadtman, 1986; Okabe et al., 1983), carrier 
mediated transport (Dubbelman et al., 1980) as well as the 
loss of barrier functions (Deuticke et al., 1986; Okabe et 
al., 1983; Grankvist and Marklund, 1986). The various 
biophysical consequences reported are changes in membrane 
fluidity (Bruch and Thayer, 1983) and rigidification of 
membrane skeleton (Shohet and Mohandas, 1985). 
Lipid peroxidation occurs both enzymatically and 
nonenzymatically (Kim et al., 1988). It was reported that 
nonenzymatic autoxidation yields random hydroperoxide 
isomers that are implicated in certain types of membrane 
pathology, while the enzymatic peroxidation of 
polyunsaturated fatty acids in biomembranes is a controlled 
process that yields specific positional and configurational 
isomers of hydroperoxides. The two most important and well 
studied enzymatic lipid peroxidation systems are the NADPH-
dependent lipid peroxidation, where reducing equivalents 
are provided by the NADPH-cytochrome P450 reductase 
catalyzed reduction of iron by NADPH, and superoxide-
dependent lipid peroxidation, where reducing equivalents are 
provided by xanthine oxidase catalyzed reduction of O, by 
22 
xanthine (Chatterjee and Agarwal, 1988). Mammalian 
lipoxygenase is another class of enzyme system present in 
platelets and few other tissues that catalzes the oxidation 
of polyunsaturated fatty acid (PUFA) (Hamberg and 
Samuelsson 1974; Borgeat et al., 1976). 
Lipid peroxidation appears to be a primary process in 
a variety of pathological events including aging (Ames, 
1983; Halliwell, 1984), Batten's syndrome (Zeman, 1971)^ 
liver injury caused by ethanol (Di Luzio and Hartman, 1969) 
or chlorinated hydrocarbons (Recknagal, 1967). Some phases 
of atherosclerosis may also involve lipid peroxidation 
(Fujii and Sato, 1971). It is considered to play a key role 
in the development of cardiac lesions arising from 
myocardial infarction, ischemia and severe stress (Meerson 
et al., 1981a & b; Chien et al., 1979) and cancer (Mcbrien 
and Slater, 1982). 
Mechanism of Lipid Peroxidation : 
Biological membranes containing PUFA and bathed in 
an oxygen rich and metal ion containing fluids, are good 
target of peroxidation (White, 1973; Chatterjee and 
Agarwal, 1988). The ground state of PUFA is of singlet 
multiplicity and their reaction with oxygen is spin 
forbidden since the ground state of oxygen is of triplet 
multiplicity. The lipid peroxidation reaction thus involves 
a mechanism that circumvents the spin barrier. It occurs via 
Scheme 1 
MECHANISM OF LIPID PEROXIDATION 
Initiation 
LH -> L 
Propagation 
L + O2 > LOO 
LOO + LH -> LOOK + L 
Termination 
LOO + L 
L00° + LOO' 
-> LOOL 
-> LOOL + O. 
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a free radical mechanism and proceeds by chain reaction 
(Chatterjee and Agarwal, 1988). A single hit of the 
initiating radical induces the oxidation of many molecules 
of fatty acid and amplifies the oxidative damage. 
Lipid peroxidation is a complex process characterized 
by three distinct phases (a) slow induction phase (b) a 
rapid propagation phase catalyzed by transition metal ions 
like copper or iron (c) a slow termination phase 
(Gutteridge, 1982; Pryor, 1976) (Scheme I). The reaction 
begins with the abstraction of a hydrogen atom from PUFA 
resulting in the formation of a lipid radical (L'). The 
rearrangement of the double bonds of fatty acid results in 
the formation of conjugated diene. The lipid radical reacts 
with molecular oxygen to form lipid peroxyl radical (LOO'). 
This can abstract a methylene hydrogen from another PUFA to 
form lipid hydroperoxide and a second lipid radical (L'). 
The lipid peroxyl radical can also cyclize to form a five 
membered lipid endoperoxide radical. The lipid radical and 
lipid endoperoxide radical can react with O2 and another 
PUFA to continue the radical chain reaction. The break 
down of lipid hydroperoxide and endoperoxide leads to the 
formation of numerous products including various aldehydes 
like MDA (Wills, 1980; Gardner, 1979; Shimasaki et al., 
1982). In addition volatile hydrocarbons like ethane, 
propane, pentane (Eichenberger et al., 1982), conjugated 
diene and fluorescent carbonylamine products are also formed 
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(Chatterjee and Agarwal, 1988). 
Role of Iron in Lipid Peroxidation 
The catalytic role of iron is central both to 
enzymatic and nonenzymatic lipid peroxidation process 
(Gutteridge et al., 1979). Iron is present in abundance in 
body and is an essential element for the utilization of 
oxygen (O2). It helps to transport (hemoglobin), store 
(myoglobin) and utilize (Cytochrome) oxygen for respiration. 
Iron is also an essential constituent of numerous oxidases, 
oxygenases and antioxidant enzymes involved in aerobic 
metabolism (Gutteridge and Quinlan, 1992). 
Iron or iron salts never exist free in biological 
systems and are always present in association with 
proteins, membranes, nucleic acids or low molecular weight 
chelating agents (Halliwell and Gutteridge, 1986). This 
usually renders iron non-reactive or poorly reactive. 
Plasma also contains iron oxidising proteins that protect 
blood from iron dependent lipid peroxidation (Gutteridge 
and Stocks, 1981; Gutteridge et al. 1980; Gutteridge, 1983). 
When the protective mechanism break down as in some 
pathological conditions, the iron ions or redox active 
complexes of iron escape purposeful seguestration and become 
available to react with the reduced intermediates of oxygen 
thereby generating harmful radicals like the hydroxyl 
radical, which have sufficient reactivity to abstract 
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hydrogen atoms from unsaturated fatty acids (Gutteridge, 
1982). Besides this, formation of oxo-iron species such as 
ferryl ion (FeO^ "*") has also been implicated (Gutteridge, 
1982). 
Iron salts are also known to decompose organic 
peroxides, arising in vivo by the action of lipoxygenases 
and cyclooxygenases to alkoxy and peroxyl radicals 
(Gutteridge and Quinlan, 1992). 
Iron existing in either oxidation state i.e. both 
Fe^ "^  and Fe^ "^*" are good oxidants, although Fe are more 
potent in this respect (Gutteridge, 1982). In the iron-
catalyzed lipid peroxidation the exact nature of oxidant 
species responsible for initiation continues to be 
unresolved. Although highly reactive hydroxy1 radical can 
often be detected in some iron containing systems 
(Gutteridge, 1982; Morehouse et al., 1983; Beloqui and 
Cederbaum, 1986), but the lack of inhibitory effects of 
scavengers of hydroxyl racidal in the iron-dependent lipid 
peroxidation suggests that it plays little role atleast in 
the initiation of peroxidation in liposomal and microsomal 
systems. 
Halliwell (1981) reported that hydroxyl radicals 
could initiate the process in radiation induced lipid 
peroxidation. Tien et al. (1981a & b) observed that in iron 
salt dependent peroxidation, hydroxyl radicals do not play 
any role and proposed perferryl complex (Fe^ "'"-02) as the 
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species promoting lipid peroxidation. However its poor 
reactivity led Halliwell and Gutteridge (1983) to suggest 
ferryl complex (FeO^ "*") as the peroxidation promoting 
species. 
Minotti and Aust (1987a & b) proposed that a specific 
Fe^ '^ -02-Fe-^ "^  complex or a 1:1 ratio of Fe^ "'" to Fe-^"*" is 
required for initiation of lipid peroxidation in microsomal 
and liposomal systems. Attempts to characterize such 
complexes were however not successful (Minotti and Aust, 
1987a; Aust, 1988). Braughler et al. (1986) showed that in 
rat brain synaptosomes, the Fe^ "'"/Fe'^ '^  ratio required for 
maximal stimulation of peroxidation varied between 1:1 to 
7:1, and suggested that specific stoichiometric complex may 
not be a pre-requisite for the initiation of lipid 
peroxidation. 
Goddard and Sweeney (1987) showed that Fe"^"*" bound to 
the chelator nitriloacetate was more efficient than free 
Fe in stimulating Fe dependent lipid peroxidation in rat 
liver microsomes, thus it seems unlikely that Fe would 
detach from this strong chelator and form a complex with 
Fe . In subsequent studies Aruoma et al. (1989) further 
provided evidence against the requirement for Fe^ "*" -Fe"^"*" 
complex or a critical 1:1 ratio of Fe^ "^*" to Fe^ "*" in the 
initiation of lipid peroxidation. Using rat liver microsomes 
and ox brain lipid liposomes, they showed that Fe^ "*" 
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34- 2 + 
dependent peroxidation could be stimulated by Al and Pb 
besides Fe and these stimulations were not additive. 
Halliwell and Gutteridge (1988), Borg and Schaich (1988) had 
earlier reported that traces of preformed lipid peroxides 
are present in microsomes and liposomes. The added iron 
could be acting by decomposing these to chain propagating 
peroxyl and alkoxyl radicals rather than generating 
initiating species. However, Ko and Godin (1990) showed in 
red blood cells that attainment of optimal Fe /Fe ratio 
is pre-requisite in initiating Fe -induced lipid 
peroxidation. They reported that, the lag phase preceding 
the Fe -stimulated peroxidation of erythrocyte membrane 
lipids and the decrease in the formation of TEARS at high 
concentration of Fe-^ "^ , may both be the manifestations of 
suboptimal Fe /Fe^ "*" ratio. Addition of ascorbic acid and 
glutathione to the reaction shorten the lag phase and 
increased the rate of formation of TEARS, presumably by 
facilitating the redox cycling of iron and there by 
maintaining Fe^^/Fe^'^ ratio, as has been earlier suggested 
by Minotti and Aust(1987c). 
Iron has been used extensively to induce lipid 
peroxidation so as to elucidate the mechanism of iron 
mediated oxidative effects and to understand the role of 
such processes in pathological conditions of iron overload. 
Eidlack and Tappel (1973) showed that Fe-^ "'"-treatment of rat 
liver microsomes induces peroxidation of lipids and also 
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leads to inactivation of membrane bound enzymes such as 
NADPH-cytochrome-c-redutase and glucose-6- phosphatase. The 
disruption of the lipophilic portion of microsomal membrane 
was found to be responsible for the observed enzyme 
inactivation. 
FeSo^-induced lipid peroxidation in liposomes 
effected the membrane fluidity (Bruch and Thayer 1983). 
Using fatty acid spin probes they showed that fluidity 
decreased with peroxidation. The magnitude of fluidity 
change was greatest in the region that was rich in polyenoic 
fatty acids, most susceptible to peroxidation. 
Rehncrona et al. (1980) showed that Fe^ "*" -treatment 
resulted in peroxidation in brain cortical phospholipids and 
fatty acids as evident by the formation of the TEARS, 
conjugated diene and fluorescent material. Peroxidation was 
accompanied by a significant decrease in phosphatidyl -
ethanolamine having high content of arachidonic acid and 
docosahexaenoic acid. 
Parinandi et al. (1990) made similar observations in 
rat myocardial membrane in response to Fe^ "^  -stimulated 
peroxidation. Besides the formation of above mentioned 
products, peroxidized membrane exhibited dramatic decrease 
in extractable phospholipids also. Oyashiki et al. (1991) 
also reported the formation of conjugated diene and 
fluorescent products in intestinal brush border membrane as 
a result of Fe^ """-treatment. 
29 
L I P I D P E R O X I D A T I O N IN 
R E D B L O O D C E L L 
The red blood cells are the favorite objects to study 
lipid peroxidation both in vivo and in vitro. The 
erythrocyte contains systems catalyzing the formation and 
the degradation of oxy-radicals (Chiu et al., 1982; Stern, 
1985). Use of the erythrocyte as a model system is 
physiologically relevant because it is normally exposed to 
high intracellular and extracellular p02 in vivo (Dise and 
Goodman, 1986). In addition, erythrocytes are directly 
exposed to ingested drugs, inhaled gases and activated 
neutrophils which are capable of generating free radicals in 
the circulation (Chiu et al. , 1982; Claster et al., 1984). 
Induced oxidative membrane changes in erythrocytes are of 
interest because they serve as model for red blood cell 
membrane changes in various pathological conditions and 
hematological diseases e.g. thalassaemia, sickle cell anemia 
etc (Deuticke et al., 1987). As the erythrocyte membrane is 
rich in polyunsaturated fatty acid and is continuously 
exposed to high p02 , they are highly susceptible to 
oxidation. 
Porter (1986) reported that lipid peroxidation causes 
the conversion of the cis, cis-double bonds to cis, trans-
or trans, trans-double bond. Nikki et al. (1988) showed 
that phospholipids as well as proteins are affected during 
the peroxidation of erythrocytes, and as it proceeds, 
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potassium ions leak out, followed by the leakage of calcium 
ions, lactate dehydrogenase, aspartate transaminase and 
hemoglobin and eventually hemolysis sets in. Increased 
erythrocyte membrane permeability has also been reported by 
Chiu et al. (1982) as a consequence of lipid peroxidation. 
Erythrocyte lipid peroxidation has also been shown to 
cause cellular dehydration and reduced in vivo erythrocyte 
survival (Jain et al., 1983), reduced whole cell 
deformability (Pfafferott et al., 1982 and Jain et al., 
1983) and increased hemoglobin binding to the red blood cell 
membrane (Sauberman et al., 1981). 
The oxidation of erythrocytes by hydrogen peroxide, 
xanthine oxidase, organic hydroperoxides have been studied 
extensively. They have been known to induce hemolysis and 
membrane damage (Horwitt et al., 1963; Jacob and Lux, 1968 
and Koster and Slee, 1983a). 
Azo compunds like 2,2' azobis (amidinopropane) 
dihydrochloride (AAPH), 2,2' azobis (2,4-dimethylvaleronit-
rile) (AMVN) generate peroxyl radicals by thermal 
decomposition at a constant rate and desired site. Yamamoto 
et al. (1985) used these compounds to induce lipid 
peroxidation in human and rat erythrocyte membrane and 
observed long kinetic chain length ranging from 7-100 
molecules. The chain length longer than 1 suggested that 
oxidation occurred by free radical chain mechanism. In other 
words this shows that when one radical is generated 7 to 100 
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molecules of fatty acids are oxidized. It was also shown 
that PUFA in erythrocyte membrane decreased with time and 
arachidonic acid was consumed faster than linoleic acid, 
presumably owing to higher number of active hydrogens. 
Intact erythrocytes were also found to be oxidized by free 
radical chain mechanism when exposed to AAPH (Yamamoto et 
al., 1986). 
t-Butylhydroperoxide, a lipoperoxide analogue, has 
been used by various investigators to study lipid 
peroxidation in erythrocytes because erythrocytes exposed to 
t-butylhydroperoxide serve as model to study the effects of 
lipid peroxidation in a metabolically active cell (Trotta et 
al., 1983). t-Butylhydroperoxide treatment of erythrocytes 
caused lipid peroxidation, hemoglobin degradation and hexose 
monophosphate shunt stimulation. (Trotta et al., 1981; 1982; 
1983 and Thornalley, 1983). The degree of lipid peroxidation 
induced by t-butylhydroperoxide was found to be dependent on 
hemoglobin status of the red blood cell and was initiated 
by t-butyl radical formed by the hemolytic scission of 0-0 
of t-butylhydroperoxide by oxyhemoglobin (Trotta et al., 
1982). 
Deuticke et al. (1987) showed that a mere pulse 
treatment of erythrocytes with t-butylhydroperoxide also 
leads to development of progressive oxidative membrane 
damage inspite of the subsequent absence of exogenous 
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oxidant. Damage comprises the occurrence of ion leakness and 
subsequent colloid-osmotic lysis and lipid peroxidation. The 
presence of catalytic metal (Fe) and lack of protective 
metabolic resources were found to initiate and propagate the 
damage. Lipid peroxidation observed, however was not 
directly involved in membrane damage. The damage in t-
butylhydroperoxide treated cells most certainly involves an 
iron-catalysed Haber-Weiss reaction (Butler and Halliwell 
1982). t-Butylhydroperoxide induced lipid peroxidation has 
also been shown to inhibit Ca-pump ATPase (Rohn et al. 
1993). Earlier Chattopadhyay et al. (1992) had shown that 
Mg^ '*"-ATPase was also inhibited by Cu and ascorbic acid 
induced peroxidation. 
Jain (1984) observed that in vitro peroxidation of 
erythrocytes by H2O2 led to the accumulation of MDA and 
destabilization of phospholipid organization by 
externalization of aminophospholipids (phosphatidylserine 
and phosphatidylethanolamine) that are confined to the inner 
leaflet.Earlier Jain & Hochstein (1980a) demonstrated that 
MDA causes marked reduction in red blood cell membrane 
spectrin, which plays a major role in the maintenance of 
asymmetric phospholipid distribution across the bilayer 
(Heast et al., 1978). Thus the disturbances observed by Jain 
(1984) in phospholipid asymmmetry could be accounted partly 
by the spectrin reduction by MDA and partly due to non-
uniform distribution of crosslinks formed between MDA and 
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aminophospholipids through schiffs base. 
Jain (1985) showed that injecting the oxidant drug 
phenylhydrazine in rats, elicited response similar to that 
observed with H2O2 induced lipid peroxidation in 
erythrocyte membrane. In addition hypercoagulability was 
also observed in erythrocytes of phenylhydrazine treated 
rats, as a result of externalization of phosphatidylserine, 
which is a rate enhancing co-factor in blood coagulation 
cascade. 
Rice-Evans & Hochstein (1981) have also demonstrated 
that phenylhydrazine treatment of hemoglobin-free 
erythrocyte ghosts resulted in peroxidation of membrane 
lipids and decrease in membrane fluidity. 
Jain (1988) provided evidence for greater lipid 
peroxidation in senescent red blood cells. Age dependent 
increase in lipid peroxidation was also reported in bovine 
and rat erythrocytes (Jain and Hochstein, 1980a; Bartosz et 
al., 1982). Jain (1988) attributed the enhanced 
susceptibility of aged erythrocytes to undergo peroxidation 
to lowered activity of enzymes, like glucose-6-phosphate 
dehydrogenase and glutathione peroxidase (Clark and Shohet, 
1985; Bartosz et al., 1978; Glass and Gershon; 1984). Lipid 
peroxidation has also been reported in red blood cells of 
patients undergoing regular dialysis treatment (Paul et al. 
1993) and those suffering from hemolytic uremic syndrome 
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(Turi et al. 1994). 
The toxicity of iron arises from its ability to 
catalyse the formation of oxygen derived free radical 
species that in turn interact with cellular membrane and 
cytoplasmic constituents. Such interactions not only modify 
the functional integrity of cells but also generate toxic 
products that further modify various cellular functions 
(Rice-Evans and Baysal, 1987). 
Exposure of normal and thalassaemic erythrocytes to 
extracellular iron stress in vitro led to increased 
methemoglobin formation and decreased intracellular 
glutathione levels (Rice-Evans et al., 1985). 
Rice-Evans and Baysal(1987) subsequently demonstrated 
that exposing erythrocytes to iron stress leads not only to 
oxidation of hemoglobin but also to membrane bound 
hemichrome production. Gross morphological changes to 
echinocytic shape also occurred. Membrane damage resulted in 
MDA production and no chromolipid formation was detected. 
Ko and Godin (1990) reported a biphasic increase in 
MDA production in red blood cells exposed to iron. They 
further showed that initiation of lipid peroxidation by iron 
requires an optimal Fe^'^/Fe^'^ ratio and that peroxidation 
was enhanced by the presence of glutathione and ascorbic 
acid. 
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As said earlier, that not only lipids but proteins 
are also the potential targets of oxidation process. 
Proteins exposed to oxidized lipids undergo modifications 
such as protein-protein and protein-lipid interactions, 
amino acid damage and fluorescence formation (Tappel, 1973; 
Hochstein and Jain, 1981; Beppu et al., 1986). Dean and 
Cheesman, (1987) reported that lipid derived radicals are 
responsible for protein damage. 
EXPERIMENTAL 
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M A T E R I A L S 
The chemicals used in the p r e s e n t s t u d i e s were 
obtained from various sources as shown below.Glass d i s t i l l e d 
water was used in a l l the experiments. 
CHEMICALS 
Acrylamide 
Ammonium molybdate 
Ammonium persulphate 
l-Amino-2-napthol-4-sulfonic acid 
Butylated Hydroxy toluene 
Catalase(Bovine Erythrocyte) 
Chloroform 
Coomassie Brilliant Blue, R-250 
Desferrioxamine mesylate 
Ethylenediamine tetracetate 
Isopropanol 
Mannitol 
Methanol 
B-Mercaptoethanol 
N,N'-Methylene bisacrylamide 
Silca Gel H 
Silca Gel H plates 
Sodium bisulfite 
SOURCE 
Sigma chem.Co.,U.S.A. 
B.D.H.,INDIA. 
May & Baker Ltd.,ENGLAND. 
E.Merck Ltd.,Germany 
Sigma Chem.Co.,U.S.A. 
Sigma Chem. Co.,U.S.A. 
Qualigens Fine Chemicals, 
INDIA 
Sigma Chem.Co.,U.S.A. 
Sigma Chem. Co.,U.S.A. 
Hi Media Ltd.,INDIA. 
Qualigens Fine Chemicals, 
INDIA. 
E.Merck Ltd.,INDIA. 
Qualigens Fine Chemicals, 
INDIA. 
Sigma Chem. Co.,U.S.A. 
Hi Media Ltd.,INDIA. 
Sigma Chem. Co.,U.S.A. 
Sigma Chem.Co.,U.S.A. 
B.D.H.,INDIA 
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Sodium dodecylsulphate 
Sodium sulfite 
Sodium azide 
Sodium formate 
2-Thiobarbituric Acid 
N,N,N',N'-Tetramethylethyl-
enediamine 
Thiourea 
Tris(hydroxymethy1)aminomethane 
Sigma Chem.Co.,U.S.A. 
B.D.H.,INDIA. 
B.D.H.,INDIA. 
B.D.H.,INDIA. 
Loba Chemie Co.,INDIA. 
Koch-Light Lab Ltd 
ENGLAND 
Sigma Chem.Co.U.S.A. 
Sigma Chem.Co.,U.S.A. 
38 
M E T H O D S 
Blood 
Fresh blood collected in ACD (acid citrate dextrose) 
from goat and buffalo was used. Out dated human blood stored 
under blood bank conditions for various durations was also 
used. Prior to use, the cells were washed three times in 
isotonic (154 mM) NaCl and the "buffy coat" was removed by 
aspiration. 
Preparation of Erythrocyte Ghosts 
Erythrocyte ghosts were prepared by the method of 
Fairbanks et al. (1971) which is based on the principle of 
hypotonic lysis, described by Dodge et al. (1963). The 
washed erythrocytes were hemolysed by mixing rapidly 1 ml 
portion of the cells with 40 ml of cold 5 mM Tris-HCl pH 
7.4. The suspension was centrifuged at 12,000 x g for 30 
minutes in a refrigerated centrifuge. The resulting deep red 
supernatant was aspirated leaving the red translucent pellet 
of packed ghosts over a minute, opaque, cream coloured 
"button". Removal of the later at this stage was essential 
for minimizing contamination of ghosts with proteases. Each 
centrifuge tube was tilted and rotated to allow the loose 
ghost pellet to slide off the tightly packed button which 
could be then aspirated with little loss of ghosts. After 
three additional washes under similar conditions the pellet 
was homogenous and comprised of intact creamy white ghosts. 
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Induction of Lipid Peroxidation 
Lipid peroxidation was carried out by the method of 
Parinandi et al. (1990) with few modifications. Lipid 
peroxidation in the human erythrocyte membrane was induced 
by 0.35 mM Fe"^"*" (FeCl3) while in buffalo and goat 
erythrocyte membranes 0.6 mM Fe was used. All the 
reactions were carried out in 1.0 ml final volume consisting 
of 30 mM Tris-HCl pH 7.4 and 100 /il of packed erythrocyte 
membrane. All the incubations were carried out at 37°C in a 
shaking water bath. Control incubations were carried out in 
the absence of Fe"^  . 
In experiments where inhibition of lipid peroxidation 
by antioxidants and chelators was studied, the various 
chelators and antioxidants were added simultaneously with 
3 + 
Fe to the reaction mixture and incubation was carried out 
for 2 hours. 
Estimation of Lipid Peroxidation 
MDA, the end product of fatty acid peroxidation 
reactions, can react with TBA to form a coloured complex 
that has maximum absorbance at 532 nm. TBA reactivity of 
erythrocyte membrane was determined by the modified method 
of Stocks and Dormandy (1971). For this purpose appropriate 
aliquots of packed membrane were suspended in 0.8 ml of 30 
mM Tris-HCl, pH 7.4. To this was added 0.5 ml of 30% TCA. 
Tubes were vortexed and allowed to stand in ice for at least 
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two and a half hours. The tubes were centrifuged at 2000 xg 
for 15 minutes, 1 ml each of the supernatant was transferred 
into another tube. To this was added 0.075 ml of 0.1 M EDTA 
and 0.25 ml of 1% TBA in 0.05 M NaOH. The tubes were mixed 
and kept in a boiling water bath for 15 minutes. Absorbance 
was read at 532 nm in DU-40 spectrophotometer after the 
tubes were cooled to room temperature. EDTA was added to 
chelate any metal ion, such as iron or copper in the extract 
which otherwise may initiate lipid peroxidation during 
boiling and result in falsely elevated values. MDA 
5 — concentration was calculated using Em values of 1.56X10 M 
•"•/cm (Jain, 1988) . 
Extraction of Lipids 
The erythrocyte membrane lipids were extracted by the 
method of Rose and Oklander (1965). To appropriate aliquots 
of the membrane, isopropanol was added in the ratio (1:11) 
(membrane : isopropanol). The samples were kept at room tem-
perature for 1 hour with occassional mixing. Chloroform was 
subsequently added in the ratio (1:7 v/v). The samples were 
again left for 1 hour and then filtered. The filtrate was 
evaporated to dryness in vaccum in a rotary flask 
evaporator. The dried residue was dissolved in chloroform 
and methanol (2:1 v/v) mixture and filtered. The filtrate 
was layered with 1/5 of its volume of 0.9% saline in a 
separating funnel, gently mixed and allowed to stand at room 
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temperature, till the two phases separated. The chloroform 
layer was collected and evaporated to dryness in vaccum and 
the dried residue was dissolved in a known volume of 
chloroform. 
Estimation of Conjugated Diane 
Conjugated dienes were estimated by the modified 
method of Buege and Aust, (1978). The lipid extracted from 
the membranes according to Rose and Oklandar (1965) was 
dried under nitrogen and dissolved in 2 ml of methanol. 
Absorbance was read at 233 nm against a methanol blank. 
Conjugated diene concentration was calculated using Em value 
of 2.52X10^ M"-*-. 
Lipid Fractionation By Thin Layer Chromatography 
One dimensional TLC was carried out for qualitative 
analysis of phospholipids. The procedure followed was 
essentially that of Jain (1988) and Chandra et al. (1987). 
TLC was done on glass plates (20X20 cm) coated with silica 
gel H (0.8 mm thick). Lipids were applied in the form of 
streak. The development of the chromatogram was performed in 
glass tanks (250x250x120 cm) lined with filter paper on 
three sides. The tanks were first saturated with developing 
solvent (chloroform : methanol : glacial acetic acid : 
water, 50:25:8:4). The plates were developed in ascending 
position and the development was complete in 2-3 hrs. The 
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whole process was carried out at 10°C. The quantitative 
analysis of phospholipids was done by the procedure of 
Pollet et al. (1978). TLC was done on plastic coated silica 
gel H plates (10 cm X 10 cm). The plates were developed in 
three different solvent system as follows : 
(a) The plates were first developed in 
chloroform/methanol/water (70:30:4) from bottom to 
top. They were air dried for 30-40 minutes and then 
activated by keeping at 40°C for 5 minutes. The 
process of drying was followed after each step. 
(b) The chromoplates were rotated counter clockwise by 
90° and developed in Ilnd solvent system i.e. 
chloroform/methanol (2:8). The solvent system was 
allowed to run 2/3 the distance of the plate. 
(c) The plates were again developed in the same direction 
in the Ilird solvent system i.e. chloroform/methanol 
(2:1) from bottom to top of the plate. 
(d) Finally the plates were rotated clockwise back to 
original position and developed in chloroform/ 
methanol (2:1). 
The plates were dried at room temperature for about 
15 minutes and the lipids were detected using iodine vapour 
(Sims and Larose,l962) and ninhydrin spray in 0.2% acetone. 
Individual fractions were scrapped off after staining and 
phospholipids were eluted with chloroform : methanol (1:1) 
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(Chandra et al., 1987). The silica gel in each test tube was 
given 3 washes to ensure complete recovery of phospholipids. 
Estimation of Phospholipids 
The phospholipids were quantitated by phosphorous 
determination. The procedure used was that of Bartlett 
(1959) as modified by Marinetti (1962). The dry residue of 
lipids was digested with 1 ml of 70% HCIO^ for about 30 
minutes on an electric digesting unit. After cooling, 7 ml 
of distilled water was added to each tube followed by 1.5 ml 
of 2.5% (W/V) ammonium molybdate and 0.2 ml of 0.25% ANSA 
reagents (prepared by dissolving in 100 ml of 15% sodium 
bisulfite, 0.5 gm of sodium sulfite and 0.25 g ANSA). The 
tubes were placed in boiling water bath for 7 minutes. After 
20 minutes the colour was read at 630 nm in DU - 40 
spectrophotometer. A calibration curve was prepared in 
similar manner using KH2PO4 as standard. 
Fatty Acid Analysis 
Fatty acid esters were prepared by transmethylation 
process (Christie et al., 1973). To screw capped corning 
tubes (15x125 cm) containing the lipid sample about 20 mg, 
was added the mixture (8 ml) of methanol, benzene and 
sulfuric acid (84:10:4 V/V/V) and heated at 80°C in a 
glycerine bath for 1^ hours. After completion of the 
reaction period, excess water was added to each tube and the 
methyl esters were extracted with hexane (3x5 ml). The 
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supernatant organic layer was washed twice with water and 
solvent was evaporated under the stream of nitrogen in a 
glycerine bath at 40°C. The lipid samples were dried by 
adding 3 ml of azeotropic mixture (chloroform, methanol and 
benzene, 1:1:1, V/V/V) under the stream of nitrogen in a 
glycerine bath at 40°C. After the complete removal of 
moisture, the samples were dissolved in dry hexane and the 
tubes were flushed with nitrogen. The fatty acid methyl 
esters were analysed with Hewlett Pachard 5890 gas 
chromatograph column DB225 (20mx0.2 mm J.W. Scientific 
Folson, CA). Oven temperature was programmed to rise from 
150°C to 225°C at a rate of 10°C/min. Injector and detector 
temperatures were 200°C and 300"c respectively. Hydrogen and 
air were used for flame ionization detector (FID). The 
carrier gas N2 (ultrapure) was used at a flow rate of 0.5 
ml/min. Flow rate for total including auxiliary was 52 
ml/min. Major peaks were identified by comparison with 
standard fatty acid methyl esters. Some peaks (minor and 
major) could not be identified because of the lack of fatty 
acids standards. The data was generated using standard curve 
from different fatty acid esters. 
SDS - Polyacrylamide Gel Electrophoresis 
SDS-PAGE was performed essentially, according to the 
tris-glycine system of Laemmli (1970). Routinely a gradient 
gel of 3-15% acrylamide was used. Stock solutions of 30% 
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acrylamide containing 0.8% bis-acrylaitiide, IM Tris (pH 8.8) 
and 10% SDS were prepared. They were mixed in appropriate 
order and proportions and poured with the help of perista 
pump into the mould formed by two glass plates (8.5x10 cm) 
separated by 1.5 mm thick spacers. Bubbles and leaks were 
avoided. A comb providing a template for 7 sample wells was 
inserted into the stacking gel solution before 
polymerization began. When the polymerization was complete 
in about 1 hour, the comb was removed and wells were 
overlaid with the running buffer. Protein samples were 
prepared to give a final concentration of 1% (W/V) . SDS, 
0.5% (V/V) 6-mercaptoethanol, 0.0625 M Tris-HCl pH 6.8 and 
10% (V/V) glycerol and a trace of bromophenol blue was added 
as a tracking dye. Samples were then heated in a boiling 
water bath for about 3 minutes and applied to the wells. The 
electrode buffer contained 0.025 M Tris, 0.2 M glycine and 
0.2% SDS. Electrophoresis was performed at 100 V till the 
tracking dye reached the bottom of the gel. After the 
electrophoresis was complete the protein bands were 
detected by staining the gels with 0.1% coomassie brilliant 
blue R - 250 in 40% methanol and 10% acetic acid. Destaining 
was carried out with 10% glacial acetic acid. 
RESULTS 
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RESULTS 
Effect of Fe^ "*" on MDA formation in human, buffalo and goat 
erythrocyte membranes - Iron is known to cause lipid 
peroxidation in human erythrocyte membrane as well as in 
other biomembrane systems. Little information is however 
available about its effects on non-humanoid erythrocyte 
membrane lipids. The objective of the following studies was 
to compare the effect of Fe"^ "^  on human and non-humanoid 
erythrocyte membranes. As evident from figure 1 panel A, MDA 
formation in human erythrocyte membrane increased as a 
function of Fe'^''" concentration at 37 °C, and after an 
initial lag, significant MDA formation was observed with 
0.35 mM Fe-^"*". Increase in Fe-^"*" concentration upto 0.8 mM did 
not result in further marked increase in the formation of 
MDA. Buffalo erythrocyte membrane was markedly more 
recalcitrant to Fe -induced lipid peroxidation as compared 
3 + 
to human erythrocyte membrane (Fig. 1 panel B). Fe 
concentration upto 0.4 mM elicited negligible formation of 
MDA in buffalo erythrocyte membrane and significant amount 
of MDA was detected only when the membrane was exposed to 
3 + 
0. 6mM Fe . Goat erythrocyte membrane was least susceptible 
3 + 
to Fe -induced lipid peroxidation and treatment of 
3 + 
membrane with Fe concentrations upto 0.8mM resulted in the 
formation of barely detectable MDA (Fig. 1 panel c). 
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Experiments in which Fe"^ "^ -induced MDA formation was 
measured as function of time, also showed marked variations 
in susceptibility of human and ruminant erythrocyte 
membranes to peroxidation (Fig. 2). As seen in figure 2 
panels A and B, both human and buffalo erythrocyte membranes 
exhibit a clear lag phase followed by a more rapid increase 
in MDA production with time, attaining maximal levels at 120 
minutes. Further, the magnitude of MDA formed was relatively 
high, and lag phase shorter in the case of the former. 
• 1+ 
Incubation of the goat erythrocyte membrane with 0.6 mM Fe 
upto 120 minutes was ineffective in inducing MDA formation 
(Fig. 2 panel c). 
Effect of chelators and antioxidants on Fe-*"*"-induced 
peroxidation in human and buffalo erythrocyte membranes -
The protective effect of various chelators, quenchers and 
T+ . . . . 
antioxidants on Fe -induced MDA formation was investigated 
in human and buffalo erythrocyte membranes. These included 
the chain reaction terminating antioxidant BHT, hydroxy1 
radical scavengers mannitol, sodium formate, thiourea(also 
an iron chelator) and the enzyme catalase, that detoxifies 
H2O2. The chelating property of the specific iron chelator 
desferrioxamine and non-specific heavy metal ion chelator 
EDTA was also investigated. As shown in table 1, sodium 
formate and mannitol were ineffective in restricting MDA 
production in human erythrocyte membrane at concentrations 
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Of 7mM. Sodium azide (10 mM) , also did not show any 
inhibitory effect. The Fe"^ '*'-induced lipid peroxidation was 
however almost completely inhibited by BHT at a 
concentration much lower than that of Fe . EDTA was highly 
inhibitory(92%) while desferrioxamine showed 47% inhibition 
of lipid peroxidation when present in almost equimolar ratio 
to Fe . Catalase and thiourea also showed significant 
inhibition of MDA formation. Doubling of Fe concentration 
from 0.35 mM to 0.7 mM reduced the inhibitory effects of 
some antioxidants. 
The protective effect of the various antioxidants and 
chelators was seen on Fe -induced MDA production in buffalo 
erythrocyte membrane as well (Table 2). While BHT almost 
completely inhibited MDA formation, EDTA and thiourea showed 
more than 90% inhibition. However, sodium formate, mannitol 
and sodium azide were completely ineffective as 
antioxidants. 
Effect of Fe on conjugated diene formation in human and 
buffalo erythrocyte membranes - Conjugated dienes have 
been considered a measure of lipid peroxidation in vivo. 
Formation of conjugated dienes have been measured in 
various tissue systems like plasma, kidney and lungs in 
response to thermal injury and exposure of porcine 
intestinal brush border membrane to oxidants like iron and 
ascorbate (Till et al., 1985; Oyashiki et al., 1991). In the 
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TABLE-1 
Effect of chelators/antioxidants on Fe^^-induced lipid 
peroxidation in human erythrocyte membrane 
Addi t ions 
None 
Desferrioxamine, 0.3 mM 
EDTA, 0.7 mM 
Thiourea, 7 mM 
Sodium Formate, 7.0 mM 
Sodium Azide, 10 mM 
Mannitol, 7.0 mM 
Catalase, 120 ng 
BHT, 7 ^M 
nanomoles MDA 
rbc membrane 
0.35 mM Fe^^ 
t r e a t e d 
168±2 .4 
88±2.9 (47) 
12.7±1.5 (92) 
19±4.9 (88) 
162±2.1 (3.5) 
158±2.4 (6.0) 
164±1.8 (2.3) 
42±2.4 (75) 
8.5±1,0 (94) 
per ml packed 
0.7 mM F 
t r e a t e d 
2 3 7 ± 2 . 3 
207±1.4 
9.5±0.35 
122±3.1 
228±3.1 
236±0.3f 
235±2.4 
165±2.8 
6.9±0.15 
e^ ^ 
(12) 
(95) 
(48) 
(4.0) 
(0 .42) 
(0.84) 
(30) 
(97) 
Values are average of three individual experiments run 
in duplicate and expressed as mean ± SEM. Values in 
parenthesis represent percent inhibition calculated taking the 
value of membranes treated with respective concentrat ion of 
Fe^' alone. Time of incubation is two hours. 
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TABLE-2 
Effect of chelators/antioxidants on Fe^^ induced 
lipid peroxidation in buffalo erythrocyte membrane 
Addi t ions 
None 
Desferrioxamine, 0.3 mM 
EDTA, 1.2 mM 
Thiourea, 12 mM 
Sodium Formate, 12 mM 
Sodium Azide, 10 mM 
Mannitol , 12 mM 
Catalase, 120 ^g 
BHT, 12 nM 
nanomoles 
packed rb 
101±3 .0 
61±7 .4 
3 .3±0.2 
8.2±0.45 
88±2 .2 
99±1 .7 
98±2 .3 
19±0.70 
1.7±0.21 
MDA per ml 
c membrane 
(40) 
(96) 
(92) 
(12) 
(2> 
(3) 
(81) 
(98) 
(0.6 mM Fe^" was used to induce MDA formation). Time 
of incubation was two hours. Values are average of three 
individual experiments run in duplicate and expressed 
as mean ± SEM. Values in parenthesis represent percent 
inhibition calculated taking the value of membranes 
treated with respective concentration of Fe^^ alone. 
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present studies the formation of diene has been investigated 
in human and buffalo erythrocyte membranes in response to 
Fe"^ '*"-induced oxidative stress. The UV spectra of lipid 
extracts of human and buffalo erythrocyte membranes treated 
-J J. 
with Fe showed an increase xn absorbance around 233 nm, 
over those of extracts prepared from untreated membranes, 
indicative of diene formation (Figs. 3 and 4). The time 
course studies showed that diene concentration increased 
3 + 
with time in these Fe -treated membranes (Figs. 5A and 5B). 
In the case of human erythrocyte membrane diene formation 
increased upto 45 minutes, then declined slightly and there 
after remained unchanged upto 120 minutes (Fig. 5A) while in 
buffalo erythrocyte membrane the decline in diene formation 
after 45 minutes was not detectable and the values remained 
almost constant upto 120 minutes (Fig. 5B). 
Effect of Fe^ "*" on phospholipid con^ KJsition of human, 
buffalo and goat erythrocyte membrane- The thin layer 
chromatographic analysis of phospholipids of human, goat and 
buffalo erythrocyte membranes showed that phosphatidyl-
ethanolamine, phosphatidylserine, phosphatidylinositol and 
sphingomyelin were present in all the above three species 
while phosphatidylcholine was found only in human 
erythrocyte membrane (Fig. 6). Two dimensional TLC was also 
performed to determine the changes in phospholipid profile 
3 + 
of Fe -treated membranes. There was a decrease in 
54 
Figure 3 
Spectra of human erythrocyte membrane lipids after treatment 
with 0.35 mM Fe - Human erythrocyte membrane was treated 
with 0.35 mM Fe-^''" for 2 hours at 37 °C. The membrane 
suspension was centrifuged at 10,000 rpm for 10 min at 4°C. 
The suspernatant was discarded and pellet was extracted as 
given in the text and the extract scanned between 200 nm to 
310 nm. 
0 0 Normal membrane 
• f Treated membrane 
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Figure 4 
Spectra of buffalo erythrocyte membrane lipids after 
treatment with 0.6 niM Fe :- Buffalo erythrocyte membrane 
was treated with 0.6 mM Fe"^ "^  for 2 hours and extracted as 
given in "Methods". The lipid extract was scanned for 
conjugated diene between 200 to 310 nm. 
0 0 Normal membrane 
• • Treated membrane 
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Figure 5 
Effect of time of incubation oH Fe-^ "*'-induced conjugated 
diene formation in human and buffalo erythrocyte membranes : 
3+ 
Human erythrocyte membranes were treated with 0.35 mM Fe , 
while buffalo ghosts were treated with 0.6 mM Fe-^"*" for 2 
hours at 37°C. The suspension was centrifuged at 10,000 rpm 
at 4°C for 10 min. The suspernatant was discarded and the 
pellet washed several times with chilled 5 mM Tris-HCl pH 
7.4 to remove traces of Fe"^"*". Lipids were extracted as given 
in the "Methods" and absorbance read at 233 nm. 
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Figure 6 
Thin layer chromatography of human, buffalo and goat 
erythrocyte membrane phospholipids:- The phospholipids 
extracted by the method of Rose and Oklander (1965) were 
subjected to TLC on silica Gel H plates, to achieve 
sepration of various phospholipid classes. Buffalo liver 
phospholipids were used as standard. 
A Human erythrocyte membrane phospholipids. 
(Lane 1-Human PL, Lane 2-PE Standard, Lane 3-Liver PL) 
B Buffalo erythrocyte membrane phospholipids. 
(Lane 1-Buffalo PL, Lane 2-PE Standard, Lane 3-Liver PL) 
C Goat erythrocyte membrane phospholipids. 
(Lane 1-Liver PL, Lane 2-Goat PL) 
B 
2 3 2 3 
• 
• 
PE 
PS 
PI 
PC 
SM 
ff PE PS 
PI 
PC 
SM 
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concentration of all classes of phospholipid in human and 
ruminant erythrocyte membranes as a result of Fe -treatment 
(Tables 3,4 and 5). In human erythrocyte membrane the amino 
-phospholipids - phosphatidylserine and phosphatidyl-
ethanolamine decreased by 54% and 19% respectively. The 
phosphatidylinositol showed about 25% degradation followed 
by phosphatidylcholine, while sphingomyelin was least 
effected and showed only 7% degradation. In buffalo 
erythrocyte membrane also, the levels of phosphatidylserine 
and phosphatidylethanolamine were lowered markedly in 
response to the Fe-^ "^ -treatment and the decrease amounted to 
19% and 16% respectively. The other phospholipids namely 
phosphatidylinositol, and sphingomyelin decreased to a 
smaller extent as a result of Fe"^"*" -treatment (Table 4). 
Goat erythrocyte membrane phospholipids were least effected 
3 + 
by Fe exposure as compared to those of human and buffalo. 
The phosphatidylethanolamine and phosphatidylserine showed 
10% and 11% decrease while phosphatidylinositol and 
sphingomyelin levels decreased only by 6% and 3% 
respectively (Table 5). 
Effect of Fe-*''' on human, buffalo and goat erythrocyte 
membrane fatty acid composition- The GLC analysis showed 
that the human, buffalo and goat erythrocyte membranes have 
quite dissimilar fatty acid composition (Fig 7). The 
caprine erythrocyte membrane was found to lack arachidonic 
TABLE-3 
Effect of Fe^ ^ on human erythrocyte 
membrane phospholipids 
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P h o s p h o l i p i d 
SM 
PC 
PE 
PS 
PI 
|igP/ml packed rbc membrane 
Norma l 
53±0.94 
56±1.7 
52±2 .0 
14 .3±1 .4 
8 .0±0.4 
Fe^^-Treated 
49±1.7 
48±0.7 
4 2 ± 0 . 6 8 
6 .5±0 .38 
6 .0±0 .65 
Pe rcen t 
D e c r e a s e 
7.0 
14.0 
19 .0 
5 4 . 0 
2 5 . 0 
Values are average of two independent experiments and 
expressed as mean ± SEM. Membranes were treated with 
0.35 mM Fe^^ for 2 hours at 37°C and extracted with chloro-
form and methanol. The various phospholipid classes were 
separated by TLC and phospholipid P estimated as given in 
"Methods". The amount of phospholipid in mg can be calcu-
lated by multiplying \ig P value by 0.025. 
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TABLE-4 
Effect of Fe^ ^ on buffalo erythrocyte 
membrane phospholipids 
Phospho l ip id 
SM 
PC 
PE 
PS 
PI 
)igP/ml packed rbc membrane 
Norma l 
47.7±0.76 
n .d . 
3 0 . 0 ± 0 . 6 7 
7 .3±0 .82 
6 .5±0 .21 
Fe"^-Treated 
44.Oil.0 
n.d. 
2 5 . O i l . 0 
5 , 9 i 0 . 5 3 
6 . 0 i 0 . 2 1 
Pe rcen t 
D e c r e a s e 
6.0 
n .d . 
16 .0 
19 .0 
7.6 
Values are average of two independent experiments and expressed 
as mean i SEM. Membranes were treated with 0.6 mM Fe^^ for 
2 hours at 37°C and extracted with chloroform and methanol. 
The various phospholipd classes were separated by TLC and 
phospholipid P estimated as given in "Methods". The amount of 
phospholipid in mg can be calculated by multiplying ^g P value by 
0 .025. 
n.d.- not detected 
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TABLES 
Effect of Fe^* on goat erythrocyte 
membrane phospholipids 
P h o s p h o l i p i d 
SM 
PC 
PE 
PS 
PI 
|igP/ml packed rbc membrane 
Norma l 
6 8 . 0 ± 0 . 5 6 
n .d . 
3 7 . 5 ± 0 . 7 0 7 
2 2 . 0 ± 0 . 8 4 
9 .9±0 .24 
Fe^^-Treated 
6 6 . 2 ± 0 . 5 6 
n .d . 
33 .7±1 .3 
19 .6±0 .38 
9 .3±0 .212 
Percent 
D e c r e a s e 
3.0 
n.d. 
10 .0 
1 1.0 
6.0 
Values are average of two independent experiments and 
expressed as mean ± SEM. Membranes were treated with 0.6 mM 
Fe^ ^ for 2 hours at 37°C and extracted with chloroform and methanol. 
The various phospholipid classes were separated by TLC and phos-
pholipid P estimated as given in "Methods". The amount of phospho-
lipid in mg can be calculated by multiplying pg P value by 0.025. 
n.d, not detected 
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acid (20:4) and myristic acid (14:0). However it had a high 
content of oleic acid (18:1). Most fatty acids ranging from 
palmitic acid (16:0) to arachidonic acid were detected in 
human and buffalo erythrocyte membranes. In addition to 
these fatty acids the buffalo erythrocyte membrane has a 
high content of myristic acid. The essential fatty acid, 
linolenic acid (18:3) could not be detected in human as well 
in ruminant erythrocyte membranes. In must be admitted that 
a large fraction of the total fatty acids remained 
uncharacterised due to lack of appropriate standards. 
Treatment of human and ruminant erythrocyte membranes 
with Fe"^ "^  caused a decrease in concentration of all most all 
fatty acids except myristic acid (Tables 6,7,8). In human 
erythrocyte membrane treated with Fe"^  , the arachidonic acid 
was completely degraded followed by linoleic acid (18:2), 
oleic acid, palmitic acid (16:0) and stearic acid (18:0). In 
buffalo erythrocyte membrane the Fe treatment caused a 
remarkably significant decrease in unsaturated fatty acids 
while the decrease in saturated fatty acids (palmitic acid 
and stearic acid) was relatively very low. A small increase 
in myristic acid was also noted in Fe -treated buffalo 
erythrocyte membrane. The Fe -induced peroxidation of goat 
erythrocyte membrane caused an increase in myristic acid, 
which otherwise was completely absent in normal goat 
membrane. The linoleic acid and oleic acid were degraded to 
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Figure 7 
Diagramatic representation of fatty acid composition of 
normal human, buffalo and goat erythrocyte membranes : 
Lipids were extracted and converted to methyl esters as 
given in the text. The methyl esters were analysed by 
Hewlett-Packard 5890 gas chromatograph column DB 225. 
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TABLE-6 
Fatty acid composition of normal and 
Fe^^-treated tiuman erythrocyte membrane 
Fatty 
acid 
14:0 
16:0 
18:0 
18: 1 
18:2 
18:3 
20:4 
nanomoles fatty acid ester/mg 
membrane protein 
Norma l 
n .d . 
161 
80 
9 7 
59 
n . d . 
121 
Fe^^-Treated 
n .d . 
84 
73 
4 7 
2 4 
n . d . 
n.d. 
Membranes were treated with 0.35 mM Fe^ ^ for 2 hours at 
37°C. Lipids were extracted and converted to methylesters. They 
were analyzed by GLC and estimated as given in the text. 
n.d. = not detected 
TABLE-7 
Fatty acid composition of normal and 
Fe^^-treated buffalo erythrocyte membrane 
Fatty 
acid 
14:0 
16:0 
18:0 
18:1 
18:2 
18:3 
2 0 : 4 
nanomoles fatty acid ester/mg 
membrane protein 
Norma l 
3 6 6 
82 
77 
87 
1 8 
n .d . 
2 9 
Fe^^-Treated 
4 5 0 
73 
7 1 
57 
9 
n .d . 
2 2 
Membranes were treated with 0.6 mM Fe^^ for 2 hours 
at 37°C, The lipids were extracted and converted to 
methylesters. They were analyzed by GLC and estimated as 
given in the text. 
n.d. = not detected 
TABLE-8 
Fatty acid composition of normal and 
Fe'^ ^-treated goat erythrocyte membrane 
Fatty 
acid 
14:0 
16:0 
18:0 
18:1 
18:2 
18:3 
2 0 : 4 
nanomoles fatty acid ester/mg 
membrane protein 
Norma l 
n .d . 
6 0 
74 
176 
3 8 
n .d . 
n .d . 
Fe^^-Treated 
1 1 
59 
70 
83 
1 4 
n . d . 
n .d . 
Membranes were treated with 0.6 mM Fe^^ for 2 hours 
at 37°C. Lipids were extracted and converted to methyl 
esters. They were analyzed by GLC and estimated as given 
in the text. 
n.d. = not detected 
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considerable extent while palmitic acid and stearic acid 
underwent little oxidation. 
Effect of Fe-*"*" on human, buffalo and goat erythrocyte 
membrane polypeptide compositon- The human, buffalo and 
goat erythrocyte membranes treated with Fe"^ "^  were subjected 
to SDS-PAGE in 3%-15% gradient gels. Figures 8, 9 and 10 
show the protein profiles of human, buffalo and goat 
erythrocyte membranes respectively, treated with Fe for 
various time intervals. In the human erythrocyte membrane a 
remarkable decrease in the intensities of spectrin, band 3, 
band 5 and band 6 could be detected after 30 minutes of Fe"^ "^  
exposure. The spectrin and band 3 were nearly invisible in 
3 + 
preparations given 90 minutes of Fe -treatement. Band 4.1 
also appears to be nearly completely missing from the 
3 + 
membrane after 90 minutes of Fe -treatment. Disappearance 
of major polypeptides in the erythrocyte membrane exposed to 
3 + 
Fe was accompanied by the appearance of polymeric material 
that failed to enter the gel. 
3 + 
The effect of Fe was less pronounced m buffalo 
erythrocyte membrane. While the intensities of spectrin, 
band 3 and other polypeptides were lowered, most of these 
bands were clearly visible even in the samples treated with 
Fe-^"*" for 90 minutes (Fig. 9). The polymeric material 
retained at the top of the gel in Fe"^ "'"-treated buffalo 
erythrocyte membrane was less pronounced as compared to 
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Figure 8 
Effect of Fe on polypeptides of human erythrocyte 
membrane: Membranes prepared by hypotonic lysis were 
subjected to 0.35 mM Fe-^ "^  for 30, 45, 60 or 90 minutes 
respectively at 37°C on a shaking water bath. Reaction was 
stopped by ImM EDTA. The membranes were solubilized in 
sample buffer containing 6-mercaptoethanol, in 1:1 ratio. 
SDS-PAGE was performed on 3%-l5% gel. Approximatly 20 /ig of 
protein was loaded in each well. Lana a-normal membrane. 
Lanes b,c,d and e membranes treated for 30, 45, 60 and 90 
minutes. 
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that observed in Fe-^ "'"-treated human erythrocyte membrane. 
Like the buffalo erythrocyte membrane proteins, the goat 
3 + erythrocyte membrane proteins were more resistant to Fe 
induced oxidative stress. Fe-^ "*"-induced decrease in the 
intensities of the major bands spectrin, gp 160, band 3, 
band 4.1, band 4.2, band 5 and band 6 was observed as a 
function of time (Fig. 10). Unlike the human erythrocyte 
membrane proteins most of goat red blood cell protein bands 
3 + 
were clearly visible in samples treated with Fe for 90 
minutes. 
Effect of chelators and antioxidants on Fe"^ "*"-induced 
alterations in human and ruminant erythrocyte membrane 
polypeptides - Addition of various chelators and 
antioxidants decreased significantly the oxidative effect of 
Fe^ "^  on membrane polypeptides as seen in SDS-PAGE run in 
presence of 6-mercaptoethanol (Figs. 11, 12 & 13). In human 
erythrocyte membrane EDTA and thiourea were protective and 
the gels containing the membranes treated with Fe"^"*" in 
their presence showed high concentration of band 3, band 4.1 
and band 4.2. The disappearance of spectrin band was also 
restricted but to a lesser extent. BHT was more effective in 
protecting spectrin than band 3. Catalase was marginally 
effective in reversing the Fe-^ "'"-induced alterations, while 
sodium formate was effective in protecting band 3 and band 
4.1 to a small extent. Sodium formate, however did not 
inhibit lipid peroxidation. 
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Figure 11 
Effect of some chelators/antioxidants on Fe^ "'"-induced 
oxidation of polypeptides in human erythrocyte membrane : 
Membranes were treated with 0.35 mM Fe^ "^*" in the presence of 
various chelators and antioxidants for 90 minutes. SDS-PAGE 
was performed on 3-15% gel. Lane a normal membrane. Lane b 
membrane treated with Fe"^"*" only, for 90 minutes. Lanes 
c,d,e,f and g, membranes treated with Fe in the presence 
of 0.7 mM EDTA. 120 /xg catalase, 7 mM thiourea, 7 juM BHT, 7 
mM sodium formate respectively. 
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In buffalo erythrocyte membrane which was quite 
resistant to Fe'^ '^ -induced alterations, the protective effect 
of these antioxidants/chelators on membrane proteins was not 
very markedr^'-EDTA was most effective while BHT, thiourea, 
sodium formate and catalase offered comparatively little 
protection to membrane proteins. In goat erythrocyte 
membrane the various chelators and antioxidants used were 
quite effective in protecting membrane proteins from 
undergoing degradation /polymerization (Fig. 13). EDTA was 
most effective in protecting membrane polypeptides from 
undergoing Fe -induced oxidative modifications. Thiourea, 
BHT and catalase also exhibited significant protective 
effect on goat erythrocyte membrane proteins. The formation 
of crosslinked material was however not prevented completely 
by the inclusion of these antioxidants and was visible at 
the top of the gels. 
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DISCUSSION 
The unique role of iron in the transport and 
metabolism of oxygen in living organism primarily reflects 
the ease with which it facilitates electron transfer. 
Exposure of cells to oxygen radicals and the subsequent 
damage is therefore inseparably associated with the life 
processes. The erythrocytes of higher animals, due to the 
presence of high concentration of iron within and 
polyunsaturated fatty acids in the membrane, are 
particulary vulnerable to the potential hazards of aerobic 
environment. While the erythrocytes are certainly endowed 
with a number of antioxidants and reduction mechanisms, 
their ability to detoxify oxygen radicals is not unlimited 
and is restricted to conditions in which strict separation 
of iron and lipids is preserved. Antioxidant defence goes 
astray, when the cells become deficient in enzymes that 
maintain reducing potential of the cell and/or when 
challenged with strong oxidants or the oxidative stress 
(Hebbel, 1986). 
In the healthy erythrocytes, under normal conditions, 
the oxidative challenge begins with the generation of 
superoxide radicals, arising from the turnover of met-
hemoglobin (Carrel et al. , 1975). The superoxide radical is 
readily converted to H2O2 either spontaneously or by the 
action of SOD. The H2O2 can react with Fe(II) to produce the 
77 
hydroxyl radical as well as, hydroxyl anion and Fe(III). The 
importance of superoxide radical lies in its ability to 
reduce Fe(III) to Fe(II). The reaction can be written as 
follows (Haber-Weiss, 1934). 
H2O2 + Fe(II) — > Fe(III) + OH" + OH" 
02~* + Fe(III) — > Fe(II) + O2 
H2O2 + 02~* — > 0H~ + O2 
Since Fe(II) is required for the subsequent reactions 
involving hydroxyl radical formation, its availability is 
critical. Indeed a number of naturally occurring reductants 
like glutathione, flavanoids and ascorbate may potentially 
substitute for superoxide radical in the above reaction 
(Halliwell and Gutteridge, 1984). 
Hydroxyl radicals exhibit extremely high reactivity and 
react with a wide spectrum of organic molecules (Dorfman and 
Adams, 1973; Wilson, 1979). Location of the hydroxyl radical 
formation in the cell is therefore of utmost importance as 
the hydroxyl radical has a short life in the range of 
7xl0~ sec. (Howard, 1972). Available evidence suggests 
that cytoplasmic generation of hydroxyl radicals may be 
relatively harmless to the membrane whereas that generated 
within or in close proximity of the membrane may be critical 
in cell membrane injury (Hebbel, 1986). 
•'^  l/ViVPR*'^^ 
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It is well establis^ ved that lipid peroxidation in a 
variety of systems requires the presence of iron in various 
catalytically active forms (Braughlar et al., 1986; Piette 
et al., 1984; Minotti and Aust, 1987a; Gutteridge, 1982; 
Beloqui and Cederbaum, 1986). Although highly reactive 
hydroxyl radicals can often be detected in some iron 
containing systems, the lack of inhibitory effects of 
hydrogen peroxide degrading enzymes or scavengers of 
hydroxyl radical in the iron-dependent lipid peroxidation 
suggests that hydroxyl radicals play little, if any, role in 
the peroxidation of liposomal or microsomal systems 
(Gutteridge, 1982 and 1984; Morehouse et al., 1983; Beloqui 
and Cederbaum, 1986). 
With regard to the mechanism of iron catalyzed lipid 
peroxidation, the nature of the oxidant species responsible 
for initiating the reaction is still unresolved, 
(Minotti and Aust, 1987a«b; Aruoma et al., 1989). Minotti 
et al. (1987a & b) have proposed that a specific Fe'^^-Oj-
Fe^ complex or at least a 1:1 ratio of Fe^ '*' to Fe"^ ^ acts as 
an initiator of peroxidation in liposomal and microsomal 
systems. Other studies involving the peroxidation of rat 
brain synaptosomes (Braughler et al., 1986) or rat liver 
microsomes (Goddard and Sweeney, 1987) also support this 
hypothesis. On the other hand Aruoma et al. (1989) have 
presented evidence arguing against the essential requirement 
of a Fe^ '^ -02-Fe-^ "'" complex or a specific ratio of Fe"^"*" to 
2+ • Fe in the initiation of lipid peroxidation. 
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MDA and several MDA like aldehydes and ketones 
generated during peroxidation of phospholipids react with 
TBA (Bird and Draper, 1984). However for the sake of 
simplicity TBA reactivity is taken as a measure of MDA 
formation (Chatterjee and Agarwal, 1988). Using high 
concentrations of Fe^ "*" and longer time of incubation we 
could demonstrate concentration and time dependent increase 
in Fe-^ "'"-induced MDA formation in human and buffalo 
erythrocyte membranes (Figs.l and 2 ). Time dependent and 
concentration dependent increase m Fe" -induced MDA 
formation has also been reported in, rat heart myocardial 
membrane (Parinandi et al., 1990), porcine intestinal brush 
border membrane (Ohyashiki et al., 1991) and in brain cortex 
(Rehncrona et al., 1980). The buffalo erythrocyte membrane 
was more recalcitrant to Fe -induced peroxidation as 
compared to human erythrocyte membrane (Figs. IB and 2B), 
while goat erythrocyte membrane showed barely detectable 
ability to produce MDA (Figs. IC and 2C). It has been 
demonstrated by Goldstein et al. (1980) and Hebbel (1986) 
that the levels of the cellular protective enzymes and 
membrane vitamin E may not be the same in all animal species 
investigated and may even vary from one individual to 
another within the same species. Such differences and those 
in fatty acid composition as discussed later may account for 
the observed resistance of ruminant erythrocyte membrane to 
3 + 
Fe -induced lipid peroxidation. 
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A likely explanation for the lag phase observed in 
initiation of lipid peroxidation in human and ruminant 
erythrocyte membranes (Figs. 1 and 2) is the lack of sub-
optimal Fe-^ "'"/Fe^ "*' ratio. Ko and Godin, (1990) reported that 
Fe -induced active lipid peroxidation is preceeded by 
significant lag, presumably resulting from unfavourable 
Fe'^ '^ /Fe ratio. Furthermore these workers reported that the 
presence of ascorbic acid and glutathione during the 
reaction shorten the lag phase by facilitating the redox 
-3 1 p J. 
cycling of iron and thereby maintaining optimal Fe /Fe 
ratio. 
Due to lack of permeability barrier in the 
hemoglobin- free erythrocyte ghosts the protective role of a 
number of free radical quenchers, chelators and catalase on 
Fe^ "*"-induced MDA formation in human and buffalo erythrocyte 
membranes were investigated (Tables 1 and 2). The Fe -
induced lipid peroxidation was found to be inhibited by BHT, 
both in human and buffalo erythrocyte membranes (Tables 1 
and 2). BHT, a chain reaction terminating antioxidant 
(Porter, 1980), has been shown earlier to block Fe-^ "*"-
mediated lipid peroxidation of erythrocyte membrane (Ko and 
Godin, 1990; Braughler et al., 1986; Piette et al., 1984), 
restrict the membrane polyunsaturated fatty acid 
degradation and ensuing leak formation in erythrocytes 
exposed to iodoacetate, vandate and ferricyanide (Heller et 
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al., 1987). It is likely that inhibitory action of BHT is 
related to its oxy-radical scavenging activity (Heller et 
al., 1987). 
The inability of mannitol and sodium formate to 
inhibit peroxidation in human and ruminant erythrocyte 
membranes (Tables 1 and 2) indicate that hydroxyl radicals 
may not be directly involved in Fe-^ "''-induced lipid 
peroxidation. Similar observations were made by Ko and 
Godin (1990) with human erythrocyte membranes. They 
reported that Fe-^ "'"-induced lipid peroxidation was not 
inhibited by the hydroxyl radical scavengers mannitol and 
dimethyl sulfoxide. The protective role of thiourea, in 
Fe -induced peroxidation in human and buffalo erythrocyte 
membranes may be attributed to its iron chelating rather 
than hydroxyl radical scavenging property (Ko and Godin, 
1990). The inhibitory action of EDTA and DM is also 
presumably mediated by their iron chelating property. DM 
forms catalytically inactive complexes only with 
Fe(III)ions (Sadrzadeh et al., 1984), although it has been 
shown to form complexes with vandate also (Darr and 
Fridovich, 1985). A reduction in the inhibitory effects of 
DM and thiourea in human erythrocyte memb rane, with 
increase in Fe-^"*" concentration, further supports the 
involvement of iron chelation as their mode of action. 
Catalase that degrades H2O2, showed 70-80% inhibition of 
3 + • Fe -induced MDA production in human and buffalo erythrocyte 
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membranes, suggesting the role of H2O2 in Fe"^ "*"-induced lipid 
peroxidation in the erythrocytes. Based on these observation 
and earlier studies of Ko and Godin, (1990) it is very 
likely that both oxygen derived free radicals and a specific 
ratio of ferrous and ferric ions, may be instrumental in the 
initiation of lipid peroxidation process. 
Besides MDA, lipid hydroperoxides and conjugated 
dienes are also generated during peroxidation of 
phospholipids (Chatterjee and Agarwal, 1988). The conjugated 
dienes appear to be formed in direct proportion to the lipid 
hydroperoxides and thus may be a sensitive index of lipid 
peroxidation (Chatterjee and Agarwal, 1988). But the 
detection of small amount of conjugated diene poses problem, 
as diene absorption appears as a small shoulder on a high 
background absorption. In our studies Fe -treated human and 
buffalo erythrocyte membrane extract showed the 
characteristic enhanced absorbance around 23 3 nm due to 
production of conjugated dienes (Figs. 3 and 4). Parinandi 
et al. (1990) also showed an increase in absorbance at 233 
nm in Fe -treated rat myocardial membranes indicating 
diene formation. As evident in figures 5A and 5B, Fe-'"^ -
induced diene formation was time dependent both in human and 
buffalo erythrocyte membrane corroborating the observation 
made by Rehncrona et al. (1980) in brain cortical lipids. 
The conjugated dienes appear to be the product of double 
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bond shift that occurs during the radical chain reaction and 
also seems to be Involved in crosslinking of lipids leading 
to polymer formation (Gerald, 1995). 
Phospholipid analysis of untreated human and ruminant 
erythrocyte membranes by one dimensional TLC (Fig. 6) 
revealed the absence of phosphatidylcholine in ruminant 
erythrocyte membrane which is consistent with the earlier 
findings of Turner (1957), Nelson (1967) and Farooqui et al. 
(1987). Fe •^ ''"-treatment caused a decrease in the 
concentration of all phospholipid classes of human 
(Table 3) and ruminant (Tables 4 and 5) erythrocyte 
membranes. However, the decrease in phospholipid classes was 
more pronounced in human erythrocyte as compared to ruminant 
erythrocyte membranes. Although goat erythrocyte membrane 
was remarkably more recalcitrant to Fe -induced MDA 
formation, the decrease in phospholipids was not very low 
as compared to that of buffalo erythrocyte membrane. Both 
in human and ruminant erythrocyte membranes the amino-
phospholipids, phosphatidylserine and phosphatidyl-
ethanolamine decreased significantly while sphingomyelin 
underwent very little degradation. The phosphatidylinositol 
decreased appreciably in human erythrocyte membrane (25%), 
while in goat and buffalo it decreased by only 6% and 7.6% 
respectively. The differences seen in the susceptibility of 
the various phospholipid classes of human and ruminant 
erythrocyte membranes to undergo peroxidation may be a 
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reflection of differences in their PUFA concentration as 
has been suggested earlier (Rehncrona et al., 1980). Heller 
et al. (1987) reported nearly 40% decrease in both 
aminophospholipids (phosphadidylserine and phosphatidyl-
ethanolamine) in human erythrocytes exposed to vandate, 
iodoacetate and ferricyanide. A pronounced decrease in 
aminophospholipid, particularly phosphatidylethanolamine 
followed by cardiolipin, phosphatidylcholine and 
phosphatidylinositol was also observed in rat myocardial 
membrane, as a result of Fe -induced peroxidation 
(Parinandi et al., 1990). Decrease in total phospholipids 
and individual classes from membrane preparations exposed to 
free radical generating systems has been reported in rat 
liver microsomes (Bidlack and Tappel, 1973), dog heart 
sarcolemma (weglicki et al. , 1989) and bovine heart 
submitochondrial particles (Narabayashi et al., 1982). 
In addition, the observation of Parinandi et al. 
(1990) that the peroxidized phospholipids having 
polyunsaturated acyl group at Sj^ _2 position and saturated or 
monounsaturated at Sj^ .-,^  position forms crosslink with 
protein and thus becomes inextractable, may also likely 
explain the observed decrease in all phospholipid classes 
in human and ruminant erythrocyte membranes treated with 
Fe-^ "^  (Tables 3-5) . 
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Fatty acid analysis of normal human and ruminant 
erythrocyte membranes (Fig. 7) showed complete absence of 
arachidonic acid in goat red blood cell membrane 
corroborating the observation of Marin et al. (1990) who 
reported the presence of only 2%-3% arachidonic acid in the 
closely related sheep erythrocyte membrane. The goat 
erythrocyte membrane is however rich in oleic acid like 
3 + 
sheep erythrocyte membrane (Marin et al. , 1990). The Fe -
treated erythrocyte membranes of human, goat and buffalo 
showed a decrease in all the major fatty acids (Tables 6,7 
and 8). There was a complete degradation of arachidonic acid 
in human erythrocyte membrane. Lipid peroxidation has been 
reported to cause a decrease in the polyenoic acid content 
in various tissues (Parinandi et al., 1990; Hammer and 
Wills, 1978). Yamamoto et al. (1985) reported a decrease in 
arachidonic and linoleic acid in human erythrocyte membrane 
exposed to the oxidizing agent AAPH. About 60% decrease in 
arachidonic acid (20:4) and 80% in docosahexaenoic (22:6) 
was reported in human erythrocyte membrane exposed to 
iodoacetate, vandate and ferricyanide (Heller et al., 1987). 
Evidences are also available in support of iron-mediated 
free radical-induced degradation of PUFA, alteration of 
phospholipids and increased level of MDA with concomitant 
functional alterations in various membrane systems in 
vitro, including microsomal systems (Miller and Aust, 1989; 
May and Mc Cay, 1968; Weglicki et al.,1989; Poyer & Mc Cay, 
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1971; Narabayashi et al., 1982). 
The appearance of substantial amount of myristic acid 
in Fe"^ "^  - treated goat erythrocyte membrane and an increase 
in buffalo erythrocye membrane is consistent with the 
findings of Parinandi et al. (1990) who reported that 
Fe^Vascorbate treatment of rat myocardial membrane caused a 
decrease in PUFA accompanied by an increase in saturated 
fatty acids. Although goat erythrocyte membrane is 
recalcitrant to Fe•^ ''"-induced MDA formation, the decrease in 
fatty acid is significant, which may be attributed to 
alternative modes of degradation as discussed subsequently. 
The difference observed in the susceptibility of 
human, buffalo and goat erythrocyte membranes to lipid 
peroxidation may be primarily governed by their respective 
fatty acid compositions (Hammer and Wills, 1978). It has 
been reported that in rats fed with fish oil, higher levels 
of TEARS were detected in liver endoplasmic reticulum as 
compared to controls , owing to the presence of high level 
of eicosapentaenoic acid (20:5) and docosahexaenoic acid 
(20:6) (Hammer and Wills, 1978).Novikoff hepatoma cells were 
also found to resist in vitro oxidative stress owing to 
lower levels of arachidonic (20:4) and docosahexaenoic acid 
(22:6) as compared to normal liver cells (Cheesman et. al, 
1986). Gatti et al. (1993) also reported that erythrocytes 
from alcoholic individuals offer increased resistance to 
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free radical damages because of significantly lower 
docosahexaenoic acid content as compared to red blood cells 
from non-alcoholic individuals. In addition,different levels 
of membrane bound antioxidant enzymes in ruminant and human 
erythrocytes may be responsible for their different 
susceptibility to Fe^ "^^  -induced lipid peroxidation (Suzuki 
et al., 1984). 
High MDA formation and other oxidative changes 
accompanying peroxidation in human erythrocyte membrane as 
compared to ruminant may also be related to lower levels of 
membrane bound glutathione peroxidase (Hill and Thornalley, 
1983) or high concentration of arachidonic acid (Chatterjee 
and Agarwal, 1988). Parage et al. (1990) showed that t-
butylhydroperoxide induced TEARS formation in human 
erythrocyte membrane ^ directly correlated with the membrane 
arachidonic acid content. Girelli et al. (1994) also made 
similar observations in human erythrocyte membrane and 
reported that unsaturation index of fatty acid was the most 
important predictor of TEARS formation, and that TEARS 
formation increases with increasing concentration of total 
omega-3 polyunsaturated fatty acids especially 
eicosapentaenoic acid (20:5, omega-3) and decreases with 
increasing concentration of monounsaturated and saturated 
fatty acids. The higher level of glutathione peroxidase 
(Suzuki et al., 1984) and lesser content of arachidonic acid 
(20:4) (Table 7) in buffalo and its absence in goat 
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erythrocyte membrane (Table 8) may explain the low or lack 
of formation of MDA in these membranes on treatment with 
Fe^ "^^ . Surprisingly, while Fe •^ ''"-induced lipid peroxidation 
could not elicit significant amount of MDA formation in goat 
erythrocyte, decrease in various phospholipid classes was 
significant which may be related to alternative modes of 
degradation leading to the formation of hydroperoxide, 
hexanal, carbonylamine fluorescent products and volatile 
hydrocarbons rather than MDA (Chatterjee and Agarwal, 1988). 
A number of investigators have reported that lipid 
peroxidation of the membrane may be accompanied by 
significant alterations in membrane polypeptides. They may 
either undergo proteolysis or aggregation with other 
proteins and lipids (Desai and Tappel, 1963; Kim et al., 
1985; Koster et al., 1982 & 1983b; Frank et al., 1989 and 
Amiic et al., 1989). Dean and Cheeseman (1987) proposed a 
relationship between lipid peroxidation and protein 
modification and stated that lipid derived radicals may be 
responsible for protein damage. A gross time dependent 
decrease in the intensities of major protein bands have been 
observed in Fe^"^- exposed human, buffalo and goat 
erythrocyte membranes (Figs. 8,9 & 10). Similar observations 
have been reported by Yamamoto et al. (1985), in human 
erythrocyte membrane treated with AAPH. They reported that 
spectrin and band 3 decreased and high molecular weight 
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3+ protein increased with the extent of oxidation in the Fe -
treated membranes. 
The effect of Fe-^ "^ -treatment on buffalo and goat 
erythrocyte membrane polypeptides was less pronounced 
(Figs. 9 & 10) as compared to that seen in human 
erythrocyte membranes (Fig. 8). Although the intensity 
of spectrin, band 3 and other polypeptides was lowered in 
3 + buffalo and goat erythrocyte membranes exposed to Fe , 
most of these bands were clearly visible in the gels 
containing membranes treated with Fe"^"*" for 90 minutes (Figs. 
9 and 10). In human erythrocyte membrane spectrin and band 3 
3 + 
were nearly invisible after 90 minutes of Fe -treatment 
(Fig. 8). The formation of high molecular weight protein 
aggregates was observed in both, Fe -treated human and 
ruminant erythrocyte membranes but it was far less 
pronounced in the case of the later (Figs. 9 and 10). Since 
electrophoresis was performed in the presence of B-
mercaptoethanol, the possibility of the disulfide bonds 
contributing to the formation of polymeric material may be 
excluded. 
Formation of high molecular weight protein adducts 
and disappearance of bands 1,2,3,4.1,4.2, 5 and 6 has also 
been reported in t-butylhydroperoxide treated human 
erythrocyte membranes. (Beppu et al., 1987; Deuticke et al., 
1987 and Koster & Slee, 1983a). Beppu et al. (1987) also 
showed that although the treatment of human erythrocyte 
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membrane with ADP-Fe'^ "'' resulted in significant increase in 
lipid peroxidation, but the formation of intermolecularly 
crosslinked proteins was very small. Most of the proteins in 
the ghosts were modified without being crosslinked as 
evident by the incorporation of -^H in ADP-Fe-^ "*'-treated 
membrane proteins after reduction with NaB-^ H^ . A mixture of 
various aldehydes produced during lipid peroxidation react 
with amino group of proteins forming schiff's base and thus 
modify the protein (Beppu et al., 1987). This is contrary 
to the observation made in human, buffalo and goat 
3 + 
erythrocyte membranes (Figs. 8,9 and 10) where Fe -
treatment resulted in the formation of high molecular weight 
protein adducts visible at the top of gel. 
Diminution of protein bands especially band 5 and 
spectrin and formation of polymeric material seen in human 
erythrocyte membrane treated with lipid soluble oxidant AMVN 
(Takenaka et al., 1991) is however consistent with our 
results. It is likely that the high molecular weight 
proteins observed at the top of gels (Figs 8,9 & 10) may 
involve aggregation similar to that observed in the presence 
of calcium ions (Lorand et al. 1983) or may represent a 
complex of peroxidized bi/multivalent lipids and proteins 
(Yamamoto et al., 1985). It is of interest to note that 
ruminant erythrocyte membrane is recalcitrant to Ca"'"'*' 
activated protein crosslinking as well (Khan and 
Saleemuddin, 1988). 
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Jain and Hochstein (1979, 1980b) and Rice-Evans and 
Hochstein (1981) have reported that the formation of high 
molecular weight protein occurs subsequent to peroxidation 
of membrane lipids. However, they cautioned that other 
polymerization reactions are also possible e.g. a direct 
radical attack on the proteins (Hochstein and Jain, 1981). 
This latter possibility was substantiated somewhat by the 
formation of high molecular weight protein in illuminated 
erythrocytes in the presence of protoporphyrin (De Goeij et 
al., 1975). This crosslinking of membrane proteins was 
claimed to be independent of the process of lipid 
peroxidation (Dobbelman et al., 1978). Koster & Slee (1983a) 
also supported the possibility, that the crosslinking of 
proteins in t-butylhydroperoxide treated erythrocyte 
membrane was independent of the lipid peroxidation and 
stated that protein crosslinking was the result of a direct 
attack of the radical on the proteins. Our observations 
with the protective effects of sodium formate on protein 
aggegation but not on MDA formation in human buffalo 
erythrocyte membrane, supports this (Figs. 11 and 12, Tables 
1 and 2). Moreover BHT which prevented MDA formation was 
only partially effective in protecting the protein 
aggregation. However data implicating lipid involvement in 
crosslinking between proteins is also available (Kikugawa 
and Beppu, 1987) . 
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The influence of various chelators and antioxidants 
that inhibit MDA formation, on high molecular weight protein 
adduct formation in Fe'^ ''"-treated human, buffalo and goat 
erythrocyte membranes was investigated (Figs. 11, 12, and 
13). The effect of Fe"^"*" on human erythrocyte membrane 
polypeptides was partly reversed by inclusion of EDTA, 
thiourea, catalase, BHT and sodium formate, and some of the 
bands which would otherwise disappear after Fe-^ "'"-treatment 
of membrane, were still present. The formation of high 
molecular weight protein adducts, however was not completely 
inhibited (Fig. 11). Although significant protective effect 
of these chelators and antioxidants, especially EDTA and 
thiourea, was seen on Fe-^ ''"-treated goat erythrocyte membrane 
proteins, the crosslinked proteins were clearly visible at 
the top of the gel (Fig. 13). In buffalo erythrocyte where 
the Fe"^ "^ -induced alterations in membrane proteins were not 
very significant (Fig. 9), the protective effects of 
chelators and antioxidants were also less markedii The 
ability of EDTA to protect the membrane proteins from the 
oxidative effect of Fe'^"'' may be related to its chelating 
property, while that of thiourea may be accounted by its 
interaction with products formed during lipid peroxidation 
as suggested by Koster and Slee (1983a). These observations 
indicate that only some of the Fe"^ "^ -induced alterations in 
the polypeptide profile of erythrocytes may be directly 
related to lipid peroxidation. 
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These studies suggest that difference observed 
between human and ruminant erythrocytes m Fe -induced MDA 
formation may infact be attributed, as discussed, to the 
fatty acid composition of ruminant erythrocyte membranes. 
In view of the nature of protective effect of quenchers and 
antioxidants on Fe •^ "'"-induced lipid peroxidation, it is very 
likely that oxygen derived radicals mediate this process. 
3 + • . . . 
Fe -induced protein modifications/damage, paralleled lipid 
peroxidation but responded some what differently to the 
action of quenchers/chelators implying that lipid derived 
radicals may not be solely responsible for all the 
alterations in protein profile and other factors may also 
contribute to this process. 
SUMMARY 
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SUMMARY 
The involvement of iron in lipid peroxidation 
reactions within biological membranes is well established. 
Moreover, iron-dependent lipid peroxidation is thought to 
play a central role in pathologically relevant oxy-radical 
induced tissue damage in vivo. A detailed investigation of 
the iron-mediated oxidative effects on human, buffalo and 
+3 
goat erythrocyte membranes was therefore undertaken. Fe -
induced lipid peroxidation, as measured by the formation of 
MDA was investigated in human,buffalo and goat erythrocyte 
membranes. MDA formation increased as a function of Fe 
concentration as well as time,both in human and buffalo 
erythrocyte membranes. The buffalo erythrocyte membrane was 
however more recalcitrant to peroxidation as compared to 
human erythrocyte membrane and significant amount of MDA was 
formed only when the membrane was exposed to 0.6mM Fe .The 
amount of MDA formed m Fe -treated human erythrocyte 
membrane was considerably higher as compared to that seen in 
Fe -treated buffalo erythrocyte membrane. The goat 
erythrocyte membrane was least susceptible to Fe"^  -induced 
lipid peroxidation and barely detectable MDA was formed even 
in the presence of high concentration of Fe"*"^ . 
The protective effect of various chelators,quenchers 
and antioxidants on Fe"*"-^ -induced MDA formation was 
investigated in human and buffalo red blood cell membranes. 
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In human erythrocyte membrane, BHT and EDTA nearly 
completely inhibited Fe"*""^ -induced lipid peroxidation, and 
the antioxidant thiourea caused about 88% inhibition. 
Catalse that detoxifies H2O2 was also highly effective in 
preventing Fe"*" -induced MDA formation. Desferrioxamine, the 
specific chelator of ferric ions showed only 47% inhibition 
of lipid peroxidation, while hydroxyl radical scavengers 
mannitol and sodium formate were completely ineffective in 
this regard. BHT,EDTA and thiourea showed almost complete 
inhibition of Fe^ -^ -induced lipid peroxidation in buffalo 
erythrocyte membrane also, while sodium formate and mannitol 
were ineffective as antioxidants. 
The UV spectra of lipids extracted from Fe"*""^ -treated 
human and buffalo erythrocyte membrane showed an increase in 
absorbance around 23 3nm, indicative of diene formation. 
Diene concentraction increased as a function of time both in 
human and buffalo erythrocyte membranes. 
The phospholipid analysis of human, buffalo and goat 
erythrocyte membranes showed that phosphatidylserine, 
phosphatidylethanolamine, phosphatidylinositol and sphingo-
myelin were present in all the three species while 
phosphatidylcholine was found only in human erythrocyte 
membrane. The Fe"'"^ -induced lipid peroxidation was 
accompanied by decrease in concentration of all phospholipid 
classes in human,buffalo and goat erythrocyte membranes. The 
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decrease was more pronounced in the content of the 
aminophospholipids - phosphatidylserine and phosphatidyl-
ethanolamine and less marked in case of sphingomyelin in 
all the three species. In comparison to human and buffalo 
erythrocyte membrane phospholipids,the goat erythrocyte 
membrane phospholipid decreased to a smaller extent as a 
+ 3 
result of exposure to Fe 
Goat erythrocyte membrane was found to lack 
arachidonic acid completely, while it was found in 
significant quantities in human and buffalo erythrocyte 
+ '? . . . • • 
membranes. Fe -induced lipid peroxidation caused a 
decrease in fatty acids in human as well in ruminant 
erythrocyte membranes. A small increase was also noted in 
myristic acid. The arachidonic acid was found to be 
completely degraded in human erythrocyte membrane as a 
result of Fe"*" -treament. 
There was a decrease in the intensities of major 
protein bands of human and ruminant erythrocyte membranes as 
a result of Fe"*" -treatment. The decrease was however less 
pronounced in ruminant erythrocyte membrane proteins. 
Spectrin as well as band 3 which were nearly invisible after 
90 mins. of Fe"^-^-treatment in human erythrocyte membrane^ 
were clearly visible in ruminant erythrocyte membrane after 
the treatment. A significant increase in the high molecular 
weight protein aggregate that failed to enter the gel was 
also observed in the Fe"*""^-exposed human and ruminant red 
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blood cell membranes. Since electrophoresis was carried out 
in the presence of 6-merca^toethanol, the possiblity of the 
material being disulfide bonded may be excluded. 
The influence of various chelators and antioxidants 
that inhibit MDA formation, on Fe •'-induced protein 
polymerization/degradation was also investigated. EDTA, 
thiourea, BHT and catalase were capable of partly reversing 
the effect of Fe on membrane polypeptides m human and 
ruminant erythrocytes and some of the bands which would 
rapidly disappear after Fe"*" -treatment were still 
present.The formation of high molecular weight protein 
aggregate was however not completely prevented by any of 
the agents investigated. 
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